RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | Head and Neck Neoplasms |
|
Accession: | DOID:9006169
|
browse the term
|
Definition: | Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651) |
Synonyms: | exact_synonym: | Head Neoplasms; Head, Neck Neoplasms; Neck Neoplasms; UADT Neoplasm; UADT Neoplasms; Upper Aerodigestive Tract Neoplasms; upper aerodigestive tract neoplasm |
| narrow_synonym: | Cancer of Head; Cancer of Neck; Cancer of the Head; Cancer of the Neck; Head Cancer; Neck Cancer |
| primary_id: | MESH:D006258 |
| alt_id: | RDO:0000780 |
| xref: | EFO:0004284; EFO:0005950 |
|
|
|
G |
Areg |
amphiregulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15342401 |
|
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
|
|
G |
Bap1 |
BRCA1 associated deubiquitinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25231345 |
|
NCBI chr16:6,446,709...6,455,535
Ensembl chr16:6,446,709...6,455,535
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18566236 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18566236 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17510391 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Csf3 |
colony stimulating factor 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:7692001 |
|
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19020767 |
|
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:12942316 PMID:15342401 PMID:23917044 PMID:16467544 |
RGD:5131641 |
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
severity |
ISO |
mRNA:increased expression: : |
RGD |
PMID:26659720 |
RGD:11573297 |
NCBI chr 1:79,033,342...79,047,102
Ensembl chr 1:79,033,326...79,047,102
|
|
G |
Fat1 |
FAT atypical cadherin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23354438 |
|
NCBI chr16:47,177,253...47,296,261
Ensembl chr16:47,177,248...47,296,107
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15557674 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Grp |
gastrin releasing peptide |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15342401 |
|
NCBI chr18:59,388,679...59,402,061
Ensembl chr18:59,388,274...59,402,061
|
|
G |
Mal |
mal, T-cell differentiation protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19445022 |
|
NCBI chr 3:114,864,378...114,888,136
Ensembl chr 3:114,864,378...114,888,136
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15342401 |
|
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15342401 |
|
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
|
ISO |
DNA:insertion:promoter:g.-1607insG (human) |
RGD |
PMID:19843588 |
RGD:7207056 |
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Pramex1 |
PRAME like, X-linked 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16179254 |
|
NCBI chr X:98,567,994...98,574,654
Ensembl chr X:98,569,415...98,572,096
|
|
G |
Rad51 |
RAD51 recombinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22613844 |
|
NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035
|
|
G |
Rarb |
retinoic acid receptor, beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17549354 |
|
NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288
|
|
G |
Srsf2 |
serine and arginine rich splicing factor 2 |
|
ISO |
mRNA:increased expression:head and neck (human) |
RGD |
PMID:21764905 |
RGD:11039047 |
NCBI chr10:102,052,158...102,055,365
Ensembl chr10:102,052,314...102,055,338
|
|
G |
Stat6 |
signal transducer and activator of transcription 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21765211 |
|
NCBI chr 7:63,480,229...63,497,551
Ensembl chr 7:63,479,642...63,498,495
|
|
G |
Tgfa |
transforming growth factor alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15342401 |
|
NCBI chr 4:118,618,043...118,700,897
Ensembl chr 4:118,618,269...118,700,894
|
|
G |
Tyms |
thymidylate synthetase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19020767 |
|
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
|
|
G |
Urod |
uroporphyrinogen decarboxylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21270338 |
|
NCBI chr 5:130,464,695...130,468,783
Ensembl chr 5:130,455,217...130,468,808
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16499871 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Xrcc3 |
X-ray repair cross complementing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22613844 |
|
NCBI chr 6:130,863,405...130,873,765
Ensembl chr 6:130,863,959...130,872,444
|
|
|
G |
Artn |
artemin |
|
ISO |
mRNA:increased expression:peripheral nerve: |
RGD |
PMID:19937367 |
RGD:8655552 |
NCBI chr 5:131,458,596...131,470,193
Ensembl chr 5:131,464,756...131,468,025
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
|
ISO |
mRNA:increased expression:peripheral nerve: |
RGD |
PMID:19937367 |
RGD:8655552 |
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Cav1 |
caveolin 1 |
|
ISO |
|
RGD |
PMID:20881564 |
RGD:8661782 |
NCBI chr 4:45,640,624...45,673,708
Ensembl chr 4:45,634,918...45,673,705
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
ISO |
mRNA,protein:decreased expression:myelinated nerve: |
RGD |
PMID:20600642 |
RGD:8661792 |
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO |
DNA:snp:promoter:c.-1053C>T (human) |
RGD |
PMID:12540498 |
RGD:1358568 |
NCBI chr 1:205,269,967...205,280,365
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Ercc2 |
ERCC excision repair 2, TFIIH core complex helicase subunit |
susceptibility |
ISO |
DNA:missense mutation:cds:p.D312N (rs1799793) (human) |
RGD |
PMID:20150366 |
RGD:5688735 |
NCBI chr 1:79,033,342...79,047,102
Ensembl chr 1:79,033,326...79,047,102
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
disease_progression |
ISO |
|
RGD |
PMID:15354013 |
RGD:11567268 |
NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
|
ISO |
mRNA:increased expression:peripheral nerve: |
RGD |
PMID:19937367 |
RGD:8655552 |
NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209
|
|
G |
Igf1 |
insulin-like growth factor 1 |
susceptibility |
ISO |
protein:increased expression:serum: |
RGD |
PMID:21788435 |
RGD:8548833 |
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
susceptibility |
ISO |
protein:increased expression:serum: |
RGD |
PMID:21788435 |
RGD:8548833 |
NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
|
|
G |
Nf2 |
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor |
|
ISO |
protein:decreased expression:myelinated nerve: ClinVar Annotator: match by term: Acoustic neuroma |
ClinVar RGD |
PMID:8081368 PMID:8757035 PMID:12118253 PMID:25741868 PMID:28492532 PMID:20600642 More...
|
RGD:8661792 |
NCBI chr14:79,627,399...79,710,709
Ensembl chr14:79,627,399...79,710,667
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
|
RGD |
PMID:14660915 |
RGD:8547959 |
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
|
G |
Aqp1 |
aquaporin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 5:145,908,173...145,981,552
Ensembl chr 5:145,908,181...145,985,564
|
|
G |
Arid4b |
AT-rich interaction domain 4B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr17:51,138,419...51,262,894
Ensembl chr17:51,138,535...51,262,906
|
|
G |
Arid5b |
AT-rich interaction domain 5B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr20:20,307,731...20,490,746
Ensembl chr20:20,307,731...20,487,433
|
|
G |
Aspm |
assembly factor for spindle microtubules |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr13:51,074,849...51,123,755
Ensembl chr13:51,074,849...51,123,755
|
|
G |
Atm |
ATM serine/threonine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atr |
ATR serine/threonine kinase |
treatment |
ISO |
|
RGD |
PMID:32001675 |
RGD:150340693 |
NCBI chr 8:96,426,704...96,524,152
Ensembl chr 8:96,426,724...96,524,136
|
|
G |
Atrx |
ATRX, chromatin remodeler |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr X:70,850,981...70,997,330
Ensembl chr X:70,850,981...70,997,330
|
|
G |
Bap1 |
BRCA1 associated deubiquitinase 1 |
|
ISO |
ClinVar Annotator: match by term: Adenocystic carcinoma |
ClinVar |
PMID:21642991 PMID:24894717 PMID:26166446 PMID:26452128 PMID:28492532 |
|
NCBI chr16:6,446,709...6,455,535
Ensembl chr16:6,446,709...6,455,535
|
|
G |
Bcl11a |
BCL11 transcription factor A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr14:98,029,018...98,124,181
Ensembl chr14:98,030,461...98,124,180
|
|
G |
Bcor |
BCL6 co-repressor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr X:10,609,756...10,729,613
Ensembl chr X:10,687,732...10,729,613
|
|
G |
Bcorl1 |
BCL6 co-repressor-like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr X:127,516,504...127,584,529
Ensembl chr X:127,537,538...127,584,087
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Brd1 |
bromodomain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 7:119,774,187...119,822,032
Ensembl chr 7:119,774,188...119,822,031
|
|
G |
Ccnd1 |
cyclin D1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cdh1 |
cadherin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17520682 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cmtr2 |
cap methyltransferase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr19:38,190,718...38,197,549
Ensembl chr19:38,190,642...38,197,804
|
|
G |
Cntn6 |
contactin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 4:137,354,886...137,751,712
Ensembl chr 4:137,355,367...137,751,119
|
|
G |
Crebbp |
CREB binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Dapk1 |
death associated protein kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
|
|
G |
Dtl |
denticleless E3 ubiquitin protein ligase homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr13:103,115,810...103,155,029
Ensembl chr13:103,117,186...103,154,890
|
|
G |
Dtx4 |
deltex E3 ubiquitin ligase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 1:209,457,719...209,545,163
Ensembl chr 1:209,460,735...209,492,818
|
|
G |
Efhd1 |
EF-hand domain family, member D1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr 9:87,938,259...87,984,917
Ensembl chr 9:87,938,284...87,984,917
|
|
G |
En1 |
engrailed homeobox 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr13:31,750,892...31,756,477
Ensembl chr13:31,751,545...31,755,943
|
|
G |
Ep300 |
E1A binding protein p300 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Erbin |
erbb2 interacting protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 2:34,926,962...35,028,440
Ensembl chr 2:34,928,863...35,027,852
|
|
G |
Espl1 |
extra spindle pole bodies like 1, separase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr 7:133,424,027...133,450,984
Ensembl chr 7:133,424,130...133,450,984
|
|
G |
Fanca |
FA complementation group A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr19:51,304,126...51,362,586
Ensembl chr19:51,304,021...51,362,527
|
|
G |
Fat1 |
FAT atypical cadherin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr16:47,177,253...47,296,261
Ensembl chr16:47,177,248...47,296,107
|
|
G |
Fbxw7 |
F-box and WD repeat domain containing 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 2:170,149,706...170,311,536
Ensembl chr 2:170,149,694...170,309,941
|
|
G |
Fgf16 |
fibroblast growth factor 16 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr X:70,816,658...70,828,028
Ensembl chr X:70,817,433...70,878,717
|
|
G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr17:9,461,541...9,476,268
Ensembl chr17:9,461,547...9,476,242
|
|
G |
Foxo3 |
forkhead box O3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561
|
|
G |
Foxp2 |
forkhead box P2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 4:43,133,827...43,712,442
Ensembl chr 4:43,133,912...43,711,683
|
|
G |
Gas2 |
growth arrest-specific 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr 1:101,452,361...101,582,619
Ensembl chr 1:101,482,591...101,582,619
|
|
G |
Gas6 |
growth arrest specific 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr16:76,045,430...76,075,904
Ensembl chr16:76,045,426...76,075,904
|
|
G |
Gins2 |
GINS complex subunit 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr19:48,626,770...48,639,523
Ensembl chr19:48,626,770...48,639,339
|
|
G |
Gucy1a1 |
guanylate cyclase 1 soluble subunit alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr 2:167,418,615...167,482,293
Ensembl chr 2:167,418,640...167,481,671
|
|
G |
H1f4 |
H1.4 linker histone, cluster member |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr17:41,486,574...41,487,355
Ensembl chr17:41,486,560...41,487,403
|
|
G |
Homer3 |
homer scaffold protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr16:19,132,177...19,142,739
Ensembl chr16:19,132,162...19,142,680
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
|
ISO |
ClinVar Annotator: match by term: Adenocystic carcinoma |
ClinVar |
PMID:18772396 PMID:19657110 PMID:19798509 PMID:19818334 PMID:20946881 PMID:21352804 PMID:21446021 PMID:22160010 PMID:22397365 PMID:22417203 PMID:22898539 PMID:23558169 PMID:24606448 PMID:25043048 PMID:25157968 PMID:25741868 PMID:26619011 PMID:27993330 PMID:30231226 More...
|
|
NCBI chr 9:66,534,146...66,563,703
Ensembl chr 9:66,534,146...66,563,708
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
|
|
G |
Il17rd |
interleukin 17 receptor D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr16:2,228,438...2,295,122
Ensembl chr16:2,228,287...2,292,556
|
|
G |
Insrr |
insulin receptor-related receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 2:173,255,335...173,274,800
Ensembl chr 2:173,255,414...173,274,800
|
|
G |
Irx4 |
iroquois homeobox 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr 1:30,030,561...30,039,549
Ensembl chr 1:30,030,561...30,039,549
|
|
G |
Isyna1 |
inositol-3-phosphate synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr16:18,839,143...18,841,979
Ensembl chr16:18,839,145...18,841,979
|
|
G |
Itgb4 |
integrin subunit beta 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr10:101,206,657...101,243,012
Ensembl chr10:101,206,665...101,243,012
|
|
G |
Jag1 |
jagged canonical Notch ligand 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr 3:124,406,783...124,442,220
Ensembl chr 3:124,406,794...124,442,209
|
|
G |
Jmjd1c |
jumonji domain containing 1C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr20:21,332,147...21,494,220
Ensembl chr20:21,332,147...21,463,122
|
|
G |
Kansl1 |
KAT8 regulatory NSL complex subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr10:89,237,667...89,368,735
Ensembl chr10:89,237,667...89,366,951
|
|
G |
Kat6a |
lysine acetyltransferase 6A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr16:69,084,914...69,165,923
Ensembl chr16:69,084,914...69,163,606
|
|
G |
Kdm6a |
lysine demethylase 6A |
exacerbates |
ISO |
CTD Direct Evidence: marker/mechanism DNA:mutations:multiple: (human) DNA:splice-site mutation, missense mutations:splice junction, CDS:multiple: (human) |
CTD RGD |
PMID:23685749 PMID:31483290 PMID:23685749 |
RGD:150429736, RGD:150429732 |
NCBI chr X:4,337,466...4,477,100
Ensembl chr X:4,337,750...4,477,062
|
|
G |
Kdm6b |
lysine demethylase 6B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr10:54,120,716...54,142,212
Ensembl chr10:54,121,848...54,130,794
|
|
G |
Kmt2c |
lysine methyltransferase 2C |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:23685749 PMID:31483290 |
RGD:150429736 |
NCBI chr 4:9,620,638...9,834,787
Ensembl chr 4:9,609,627...9,833,539
|
|
G |
Krt15 |
keratin 15 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr10:85,066,797...85,070,614
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Krt5 |
keratin 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr 7:132,846,132...132,851,861
Ensembl chr 7:132,846,136...132,851,850
|
|
G |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 4:126,205,663...126,811,354
Ensembl chr 4:126,206,816...126,811,691
|
|
G |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 4:14,386,389...15,870,036
Ensembl chr 4:14,386,399...15,870,240
|
|
G |
Maml3 |
mastermind-like transcriptional coactivator 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 2:135,720,431...136,137,829
Ensembl chr 2:135,721,021...136,137,814
|
|
G |
Map2k2 |
mitogen activated protein kinase kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
|
|
G |
Marcks |
myristoylated alanine rich protein kinase C substrate |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr20:40,685,315...40,691,012
Ensembl chr20:40,685,315...40,691,012
|
|
G |
Mark2 |
microtubule affinity regulating kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr 1:204,461,029...204,526,247
Ensembl chr 1:204,461,030...204,525,652
|
|
G |
Mga |
MAX dimerization protein MGA |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 3:106,851,216...106,942,908
Ensembl chr 3:106,851,140...106,941,043
|
|
G |
Mier2 |
MIER family member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr 7:10,153,501...10,169,381
Ensembl chr 7:10,153,649...10,169,378
|
|
G |
Mlc1 |
modulator of VRAC current 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr 7:120,046,705...120,067,049
Ensembl chr 7:120,046,705...120,067,049
|
|
G |
Morf4l1 |
mortality factor 4 like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 8:90,642,988...90,664,518
Ensembl chr 8:90,642,988...90,664,519
|
|
G |
Myb |
MYB proto-oncogene, transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 PMID:26829750 |
|
NCBI chr 1:15,939,771...15,973,367
Ensembl chr 1:15,939,761...15,973,057
|
|
G |
Mybl1 |
MYB proto-oncogene like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 5:9,582,905...9,618,179
Ensembl chr 5:9,582,934...9,618,183
|
|
G |
Mycbp |
Myc binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 5:136,135,955...136,143,163
Ensembl chr 5:136,135,931...136,145,616
|
|
G |
Mycn |
MYCN proto-oncogene, bHLH transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 6:35,717,764...35,723,590
Ensembl chr 6:35,717,764...35,723,590
|
|
G |
Neto2 |
neuropilin and tolloid like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr19:21,344,299...21,415,524
Ensembl chr19:21,344,289...21,417,023
|
|
G |
Nfib |
nuclear factor I/B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 5:96,759,208...96,974,001
Ensembl chr 5:96,764,653...96,975,479
|
|
G |
Notch1 |
notch receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Nsd1 |
nuclear receptor binding SET domain protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr17:9,311,963...9,426,373
Ensembl chr17:9,315,237...9,425,358
|
|
G |
Ntrk3 |
neurotrophic receptor tyrosine kinase 3 |
treatment |
ISO |
|
RGD |
PMID:23027130 |
RGD:150519921 |
NCBI chr 1:132,116,472...132,503,849
Ensembl chr 1:132,132,849...132,503,286
|
|
G |
Pcsk1n |
proprotein convertase subtilisin/kexin type 1 inhibitor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr X:14,580,036...14,583,478
Ensembl chr X:14,580,038...14,583,566
|
|
G |
Pdzk1 |
PDZ domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr 2:184,376,161...184,407,514
Ensembl chr 2:184,376,161...184,407,514
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 2:115,175,275...115,249,034
Ensembl chr 2:115,174,984...115,249,032
|
|
G |
Prkdc |
protein kinase, DNA-activated, catalytic subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr11:85,040,790...85,258,357
Ensembl chr11:85,040,792...85,257,952
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Pygb |
glycogen phosphorylase B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr 3:139,611,724...139,658,521
Ensembl chr 3:139,611,749...139,663,553
|
|
G |
Rbfox2 |
RNA binding fox-1 homolog 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr 7:108,810,627...109,054,420
Ensembl chr 7:108,810,628...109,054,691
|
|
G |
Serpinf1 |
serpin family F member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr10:60,250,198...60,262,593
Ensembl chr10:60,249,708...60,262,646
|
|
G |
Setd2 |
SET domain containing 2, histone lysine methyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 8:110,511,808...110,597,475
Ensembl chr 8:110,511,772...110,597,489
|
|
G |
Slc24a3 |
solute carrier family 24 member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr 3:132,552,119...133,051,192
Ensembl chr 3:132,551,595...133,051,192
|
|
G |
Slc3a2 |
solute carrier family 3 member 2 |
disease_progression |
ISO |
|
RGD |
PMID:23516127 |
RGD:151361211 |
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
disease_progression |
ISO |
|
RGD |
PMID:23516127 |
RGD:151361211 |
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
|
|
G |
Smarca2 |
SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 1:224,191,125...224,358,640
Ensembl chr 1:224,191,125...224,358,684
|
|
G |
Smarce1 |
SWI/SNF related BAF chromatin remodeling complex subunit E1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr10:84,159,270...84,180,547
Ensembl chr10:84,159,275...84,179,989
|
|
G |
Smc1a |
structural maintenance of chromosomes 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr X:21,103,323...21,148,053
Ensembl chr X:21,103,282...21,148,056
|
|
G |
Son |
SON DNA and RNA binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr11:30,850,890...30,923,167
Ensembl chr11:30,892,005...30,923,167
|
|
G |
Sox11 |
SRY-box transcription factor 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr 6:44,008,333...44,010,354
Ensembl chr 6:44,008,340...44,010,354
|
|
G |
Sox4 |
SRY-box transcription factor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr17:35,667,809...35,672,515
Ensembl chr17:35,667,537...35,673,665
|
|
G |
Srcap |
Snf2-related CREBBP activator protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 1:182,123,562...182,172,643
Ensembl chr 1:182,118,416...182,176,610
|
|
G |
St3gal4 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr 8:33,415,666...33,465,319
Ensembl chr 8:33,415,671...33,524,389
|
|
G |
Tlk1 |
tousled-like kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 3:55,520,559...55,627,580
Ensembl chr 3:55,503,358...55,691,968
|
|
G |
Top2a |
DNA topoisomerase II alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
|
|
G |
Tp53 |
tumor protein p53 |
disease_progression |
ISO |
ClinVar Annotator: match by term: Adenocystic carcinoma CTD Direct Evidence: marker/mechanism |
ClinVar CTD RGD |
PMID:1673792 PMID:1686725 PMID:7707106 PMID:7881428 PMID:8080050 PMID:8364550 PMID:8869100 PMID:10713666 PMID:11479205 PMID:11896595 PMID:11920788 PMID:11920959 PMID:12826609 PMID:16494995 PMID:16736287 PMID:16861262 PMID:17541742 PMID:17606709 PMID:18208484 PMID:19468865 PMID:20128691 PMID:20522432 PMID:21343334 PMID:21626334 PMID:23259501 PMID:23625637 PMID:23685749 PMID:24033266 PMID:24384472 PMID:24728327 PMID:25503501 PMID:25584008 PMID:25741868 PMID:26270727 PMID:26467025 PMID:26619011 PMID:27489289 PMID:28369373 PMID:28492532 PMID:28861920 PMID:29324801 PMID:29489754 PMID:29979965 PMID:30224644 PMID:30299350 PMID:30720243 PMID:31775759 PMID:16249115 More...
|
RGD:8547828 |
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Uhrf1 |
ubiquitin-like with PHD and ring finger domains 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23685749 |
|
NCBI chr 9:1,133,117...1,154,639
Ensembl chr 9:1,134,909...1,154,631
|
|
G |
Vcan |
versican |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr 2:20,761,718...20,860,637
Ensembl chr 2:20,761,718...20,860,637
|
|
G |
Wnt5b |
Wnt family member 5B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16762588 |
|
NCBI chr 4:152,609,566...152,733,790
Ensembl chr 4:152,609,569...152,733,407
|
|
G |
Xrn2 |
5'-3' exoribonuclease 2 |
|
ISO |
DNA:hypermethylation:3' utr: (human) |
RGD |
PMID:21692051 |
RGD:11041796 |
NCBI chr 3:134,436,916...134,509,308
Ensembl chr 3:134,437,109...134,509,306
|
|
|
G |
Hnf1a |
HNF1 homeobox A |
|
ISO |
|
RGD |
PMID:10489374 |
RGD:150540314 |
NCBI chr12:41,638,536...41,672,806
Ensembl chr12:41,645,587...41,672,104
|
|
|
G |
Cbx7 |
chromobox 7 |
|
ISO |
mRNA,protein:decreased expression:thyroid gland: mRNA:decreased expression:thyroid gland: mRNA,protein,DNA:decreased expression, loss of heterozygosity:thyroid gland: |
RGD |
PMID:19706751 PMID:18701502 PMID:18701502 |
RGD:9586729, RGD:9587357, RGD:9587357 |
NCBI chr 7:111,460,656...111,479,231
Ensembl chr 7:111,460,656...111,477,973
|
|
G |
Mir21 |
microRNA 21 |
|
ISO |
RNA:increased expression:thyroid gland: |
RGD |
PMID:20956945 |
RGD:41404697 |
NCBI chr10:71,902,600...71,902,691
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15887859 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
ClinVar Annotator: match by term: Thyroid gland undifferentiated (anaplastic) carcinoma |
ClinVar |
PMID:1565144 PMID:1631137 PMID:2046748 PMID:7732013 PMID:8423216 PMID:9242456 PMID:9399838 PMID:10864200 PMID:11782540 PMID:12672316 PMID:12826609 PMID:14743206 PMID:15390294 PMID:15607980 PMID:15607981 PMID:15951970 PMID:16401470 PMID:16818505 PMID:17540308 PMID:17606709 PMID:17636407 PMID:18511570 PMID:19454241 PMID:20128691 PMID:20407015 PMID:20516128 PMID:20693561 PMID:21343334 PMID:21484931 PMID:21519010 PMID:21552135 PMID:21761402 PMID:22186996 PMID:22811390 PMID:22915647 PMID:23161690 PMID:23246812 PMID:24677579 PMID:25584008 PMID:25741868 PMID:25787918 PMID:25952993 PMID:26014290 PMID:26230955 PMID:26332594 PMID:26467025 PMID:26585234 PMID:26681312 PMID:27276561 PMID:27374712 PMID:27463065 PMID:27680515 PMID:27895058 PMID:27959731 PMID:27993330 PMID:28453743 PMID:28492532 PMID:28873162 PMID:29489754 PMID:29979965 PMID:30224644 PMID:30327374 PMID:30816478 PMID:31882575 PMID:33300245 PMID:33372952 PMID:36988593 More...
|
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
ISO |
|
RGD |
PMID:18059332 |
RGD:13782259 |
NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
|
ISO |
DNA:hypermethylation DNA:hypermethylation:promoter |
RGD |
PMID:16229808 PMID:18664505 |
RGD:151665354, RGD:151665749 |
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Gpx7 |
glutathione peroxidase 7 |
|
ISO |
DNA:hypermethylation:promoter |
RGD |
PMID:18664505 |
RGD:151665749 |
NCBI chr 5:123,145,151...123,153,141
Ensembl chr 5:123,144,331...123,153,004
|
|
|
G |
Wdpcp |
WD repeat containing planar cell polarity effector |
|
ISO |
ClinVar Annotator: match by term: Congenital heart defects, hamartomas of tongue, and polysyndactyly | ClinVar Annotator: match by term: Heart defect - tongue hamartoma - polysyndactyly syndrome | ClinVar Annotator: match by term: WDPCP-related condition CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD |
PMID:9536098 PMID:16199547 PMID:17576681 PMID:20671153 PMID:25326635 PMID:25427950 PMID:25741868 PMID:27158779 PMID:28289185 PMID:28492532 PMID:29588463 PMID:33046855 More...
|
|
NCBI chr14:95,645,955...95,977,120
Ensembl chr14:95,646,038...95,977,113
|
|
|
G |
Atr |
ATR serine/threonine kinase |
|
ISO |
ClinVar Annotator: match by term: Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome |
OMIM ClinVar |
PMID:9536098 PMID:15987455 PMID:17010193 PMID:17576681 PMID:18414213 PMID:22341969 PMID:24033266 PMID:25741868 PMID:26845104 PMID:28492532 PMID:28518168 PMID:30262796 PMID:30995915 PMID:32461654 PMID:32522261 PMID:32606146 PMID:33057211 PMID:34008015 More...
|
|
NCBI chr 8:96,426,704...96,524,152
Ensembl chr 8:96,426,724...96,524,136
|
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
protein:increased expression:esophagus (human) |
RGD |
PMID:27188433 |
RGD:152995510 |
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
ISO |
ClinVar Annotator: match by term: Esophageal cancer, alcohol-related, susceptibility to |
ClinVar |
PMID:2987944 PMID:4065146 PMID:6650498 PMID:7180842 PMID:7593603 PMID:8903321 PMID:10627091 PMID:10780266 PMID:15654505 PMID:15902904 PMID:16046871 PMID:16440063 PMID:16679777 PMID:17885622 PMID:18056758 PMID:20010786 PMID:22992668 PMID:33355142 More...
|
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Bhlhe41 |
basic helix-loop-helix family, member e41 |
|
ISO |
protein:increased expression:esophagus(human) |
RGD |
PMID:29890466 |
RGD:151665308 |
NCBI chr 4:178,834,264...178,838,618
Ensembl chr 4:178,834,271...178,838,468
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
|
ISO |
ClinVar Annotator: match by term: Esophagus cancer |
ClinVar |
PMID:25741868 PMID:28492532 PMID:31911673 |
|
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
|
|
G |
Ctnna1 |
catenin alpha 1 |
disease_progression |
IEP |
|
RGD |
PMID:9863006 |
RGD:2289811 |
NCBI chr18:26,728,246...26,860,911
Ensembl chr18:26,728,485...26,860,910
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:20232121 |
RGD:5134997 |
NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
ISO |
|
RGD |
PMID:11833070 PMID:26782562 |
RGD:14700950, RGD:11554919 |
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
ameliorates |
ISO |
RNA:decreased expression:esophagus (human) |
RGD |
PMID:14760115 |
RGD:152025255 |
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
|
|
G |
Dcc |
DCC netrin 1 receptor |
|
ISO |
ClinVar Annotator: match by term: Esophagus cancer |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr18:64,868,987...65,972,783
Ensembl chr18:64,873,898...65,972,740
|
|
G |
Dlec1 |
DLEC1 cilia and flagella associated protein |
|
ISO |
ClinVar Annotator: match by term: Esophagus cancer |
ClinVar |
PMID:25741868 |
|
NCBI chr 8:118,826,429...118,873,183
Ensembl chr 8:118,826,466...118,873,655
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
|
ISO |
|
RGD |
PMID:29660336 |
RGD:21409755 |
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
treatment |
ISO |
DNA:hypermethylation |
RGD |
PMID:33292587 |
RGD:151665781 |
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
|
ISO |
|
RGD |
PMID:11833070 PMID:23749488 PMID:12406553 PMID:26782562 |
RGD:14700950, RGD:14700969, RGD:14700964, RGD:11554919 |
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
|
ISO |
|
RGD |
PMID:23749488 |
RGD:14700969 |
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
IEP |
protein:increased expression:esophagus |
RGD |
PMID:20498946 |
RGD:4145286 |
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Il10 |
interleukin 10 |
treatment |
ISO |
|
RGD |
PMID:26603620 |
RGD:152998997 |
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1b |
interleukin 1 beta |
treatment |
ISO |
|
RGD |
PMID:26603620 |
RGD:152998997 |
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
susceptibility |
ISO |
DNA:SNP:cds:rs11674595|rs2072472 (human) |
RGD |
PMID:31744444 |
RGD:152998961 |
NCBI chr 9:42,384,280...42,424,726
Ensembl chr 9:42,384,433...42,424,725
|
|
G |
Il5 |
interleukin 5 |
treatment |
IEP |
|
RGD |
PMID:20232121 |
RGD:5134997 |
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Lzts1 |
leucine zipper tumor suppressor 1 |
|
ISO |
esophageal squamous cell carcinoma, OMIM:133239 |
RGD |
PMID:10097140 |
RGD:1600104 |
NCBI chr16:20,542,756...20,598,204
Ensembl chr16:20,542,809...20,598,203
|
|
G |
Maf |
MAF bZIP transcription factor |
|
ISO |
ClinVar Annotator: match by term: Esophagus cancer |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chr19:43,353,867...43,713,162
Ensembl chr19:43,360,342...43,712,365
|
|
G |
Mir155 |
microRNA 155 |
|
ISO |
|
RGD |
PMID:29660336 |
RGD:21409755 |
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:23,774,654...23,774,718
|
|
G |
Mir21 |
microRNA 21 |
|
ISO |
RNA:increased expression:esophagus (human) RNA:increased expression:blood serum (human) |
RGD |
PMID:27188433 PMID:22638884 |
RGD:152995510, RGD:152998900 |
NCBI chr10:71,902,600...71,902,691
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mxi1 |
MAX interactor 1, dimerization protein |
|
IAGP |
|
RGD |
PMID:10849326 |
RGD:1298988 |
NCBI chr 1:252,323,915...252,383,682
Ensembl chr 1:252,323,303...252,383,681
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
|
ISO |
mRNA:splice variants:esophagus (human) |
RGD |
PMID:24527027 |
RGD:150519911 |
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
ISO |
protein:increased expression:esophagus (human) |
RGD |
PMID:27188433 |
RGD:152995510 |
NCBI chr 2:115,175,275...115,249,034
Ensembl chr 2:115,174,984...115,249,032
|
|
G |
Pten |
phosphatase and tensin homolog |
treatment |
ISO |
human gene and cells in a mouse model protein:decreased expression:esophagus (human) |
RGD |
PMID:20378992 PMID:27188433 |
RGD:127285592, RGD:152995510 |
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
|
ISO |
mRNA,protein:decreased expression:esophagus: |
RGD |
PMID:33862112 |
RGD:151232285 |
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
|
|
G |
Tgfbr2 |
transforming growth factor, beta receptor 2 |
|
ISO |
ClinVar Annotator: match by term: Esophagus cancer |
ClinVar |
PMID:7664267 PMID:9395234 PMID:9536098 PMID:10789724 PMID:11212236 PMID:12202987 PMID:12825850 PMID:15731757 PMID:16791849 PMID:16799921 PMID:16928994 PMID:17061023 PMID:17319955 PMID:17344846 PMID:17576681 PMID:17652900 PMID:17935258 PMID:18084123 PMID:18339844 PMID:18781618 PMID:19533785 PMID:20358619 PMID:20628007 PMID:21267002 PMID:21270064 PMID:21524434 PMID:22113417 PMID:23228659 PMID:23585368 PMID:24033266 PMID:24055113 PMID:24199744 PMID:24941995 PMID:25741868 PMID:25944730 PMID:26017485 PMID:26948038 PMID:27139629 PMID:27879313 PMID:27930701 PMID:28162229 PMID:28492532 PMID:28659821 PMID:28679693 PMID:29168297 PMID:29339704 PMID:29907982 PMID:30222965 PMID:30341550 PMID:30701076 PMID:32528524 PMID:32897753 PMID:33726816 PMID:34572573 More...
|
|
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
disease_progression severity |
ISO |
DNA:SNP:intron 6: (rs610604) (human) DNA:SNP:3'utr: (rs583522) (human) |
RGD |
PMID:25354935 PMID:26598072 |
RGD:151347597, RGD:11075880 |
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
ClinVar Annotator: match by term: Esophagus cancer |
ClinVar |
PMID:7887414 PMID:8023157 PMID:8118819 PMID:8164043 PMID:8825920 PMID:9047394 PMID:12007217 PMID:12619118 PMID:12826609 PMID:14743206 PMID:15607980 PMID:15607981 PMID:15977174 PMID:16401470 PMID:17606709 PMID:18511570 PMID:19127115 PMID:19881536 PMID:20128691 PMID:20516128 PMID:20689556 PMID:21305319 PMID:21343334 PMID:21761402 PMID:22006311 PMID:22233476 PMID:23161690 PMID:23172776 PMID:23263379 PMID:23713777 PMID:23792586 PMID:24033266 PMID:24573247 PMID:25059482 PMID:25741868 PMID:27153395 PMID:27374712 PMID:27516001 PMID:28349240 PMID:28492532 PMID:28873162 PMID:29979965 PMID:30224644 PMID:30816478 PMID:31775759 PMID:32000721 PMID:36988593 More...
|
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Wwox |
WW domain-containing oxidoreductase |
|
ISO |
ClinVar Annotator: match by term: Esophagus cancer |
ClinVar |
PMID:24456803 PMID:25411445 PMID:25741868 PMID:26467025 PMID:28492532 PMID:29358611 PMID:29808465 PMID:30356099 PMID:30853297 PMID:35573960 More...
|
|
NCBI chr19:42,432,141...43,360,278
Ensembl chr19:42,432,152...43,359,391
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
susceptibility |
ISO |
DNA:missense mutation:exon 9: p.T304A, c.910A>G (human) |
RGD |
PMID:24345911 |
RGD:150530620 |
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
|
|
|
G |
Acod1 |
aconitate decarboxylase 1 |
|
ISO |
mRNA:increased expression:esophagus (human) |
RGD |
PMID:37793345 |
RGD:596992333 |
NCBI chr15:79,871,819...79,881,101
Ensembl chr15:79,871,827...79,880,529
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
severity |
ISO |
DNA:SNPs:introns: (rs3803304, rs1130214) |
RGD |
PMID:19164214 |
RGD:408345192 |
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Birc7 |
baculoviral IAP repeat-containing 7 |
disease_progression |
ISO |
mRNA:increased expression:esophagus (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chr 3:168,047,824...168,052,606
Ensembl chr 3:168,047,824...168,052,606
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
|
ISO |
ClinVar Annotator: match by term: Carcinoma of esophagus |
ClinVar |
PMID:17972177 PMID:18431501 PMID:18627636 PMID:18779604 PMID:21120943 PMID:21218378 PMID:21523855 PMID:22126563 PMID:22293751 PMID:22486713 PMID:23555315 PMID:24055113 PMID:24728327 PMID:25637381 PMID:25741868 PMID:26467025 PMID:26689913 PMID:28222693 PMID:28492532 PMID:30702160 PMID:31131967 PMID:32467295 PMID:33471991 PMID:35464868 More...
|
|
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
|
|
G |
Dcc |
DCC netrin 1 receptor |
|
ISO |
ClinVar Annotator: match by term: Esophageal carcinoma, somatic |
ClinVar |
PMID:8187090 |
|
NCBI chr18:64,868,987...65,972,783
Ensembl chr18:64,873,898...65,972,740
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
ISO |
ClinVar Annotator: match by term: Carcinoma of esophagus | ClinVar Annotator: match by term: Esophageal carcinoma |
ClinVar |
PMID:25157968 PMID:26619011 |
|
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Grb7 |
growth factor receptor bound protein 7 |
exacerbates |
ISO |
mRNA:increased expression:esophagus mucosa (human) |
RGD |
PMID:8988034 |
RGD:151347660 |
NCBI chr10:83,443,387...83,453,057
Ensembl chr10:83,444,004...83,453,052
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
|
ISO |
ClinVar Annotator: match by term: Carcinoma of esophagus | ClinVar Annotator: match by term: Esophageal carcinoma |
ClinVar |
PMID:11150980 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19371735 PMID:19382114 PMID:19669404 PMID:20660566 PMID:20979192 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22926243 PMID:23093928 PMID:23429430 PMID:23751039 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24803665 PMID:25157968 PMID:25741868 PMID:25815234 PMID:25914166 PMID:26467025 PMID:26619011 PMID:26778095 PMID:27195699 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28492532 PMID:29493581 PMID:30055033 PMID:30138938 PMID:31394527 PMID:31560489 PMID:31564432 PMID:31775759 PMID:32165824 PMID:32371413 PMID:33372952 PMID:34008892 More...
|
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Htra1 |
HtrA serine peptidase 1 |
disease_progression |
ISO |
mRNA,protein:decreased expression:esophagus (human) |
RGD |
PMID:22935172 |
RGD:152985525 |
NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:185,497,735...185,547,379
|
|
G |
Jak2 |
Janus kinase 2 |
treatment |
ISO |
associated with Immune Deficiency Disease, human cells in mouse model |
RGD |
PMID:25724470 |
RGD:127285656 |
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Lrrc56 |
leucine rich repeat containing 56 |
|
ISO |
ClinVar Annotator: match by term: Carcinoma of esophagus | ClinVar Annotator: match by term: Esophageal carcinoma |
ClinVar |
PMID:11150980 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17412879 PMID:17979197 PMID:18039947 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19371735 PMID:19382114 PMID:19669404 PMID:20660566 PMID:21686750 PMID:21850009 PMID:22087699 PMID:22317973 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22926243 PMID:23093928 PMID:23429430 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24803665 PMID:25157968 PMID:25741868 PMID:25914166 PMID:26619011 PMID:27195699 PMID:27589201 PMID:28139825 PMID:28492532 PMID:29493581 PMID:31394527 PMID:31775759 PMID:34008892 More...
|
|
NCBI chr 1:196,299,843...196,315,170
Ensembl chr 1:196,299,846...196,315,172
|
|
G |
Map2k7 |
mitogen activated protein kinase kinase 7 |
exacerbates |
ISO |
mRNA:decreased expression:espohagus (human) |
RGD |
PMID:32831056 |
RGD:155630592 |
NCBI chr12:2,591,312...2,600,534
Ensembl chr12:2,591,219...2,604,222
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
ISO |
ClinVar Annotator: match by term: Esophageal carcinoma ClinVar Annotator: match by term: Carcinoma of esophagus | ClinVar Annotator: match by term: Esophageal carcinoma |
ClinVar |
PMID:15016963 PMID:15254419 PMID:15520168 PMID:15608678 PMID:15647370 PMID:15805248 PMID:15930273 PMID:16906227 PMID:16930767 PMID:17376864 PMID:17673550 PMID:18676830 PMID:18725974 PMID:19029981 PMID:19223544 PMID:19366826 PMID:19513541 PMID:19903786 PMID:20453058 PMID:20593314 PMID:20619739 PMID:21078999 PMID:21430269 PMID:21558396 PMID:21824802 PMID:22162582 PMID:22162589 PMID:22209294 PMID:22271473 PMID:22357840 PMID:22370636 PMID:22658544 PMID:22729222 PMID:22729223 PMID:22729224 PMID:23066039 PMID:23100325 PMID:23408298 PMID:23888070 PMID:23946963 PMID:24033266 PMID:24265155 PMID:24559322 PMID:24782230 PMID:25157968 PMID:25599672 PMID:25741868 PMID:25880439 PMID:26266975 PMID:26266985 PMID:26619011 PMID:26627007 PMID:26637981 PMID:26822237 PMID:26851524 PMID:27126994 PMID:27626068 PMID:27631024 PMID:28151489 PMID:28425981 PMID:28492532 PMID:29661094 PMID:29988677 PMID:30376034 PMID:30543347 PMID:31536475 PMID:31775759 PMID:32778138 PMID:34008892 PMID:34496175 More...
|
|
NCBI chr 2:115,175,275...115,249,034
Ensembl chr 2:115,174,984...115,249,032
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
severity |
ISO |
|
RGD |
PMID:15906366 |
RGD:151361282 |
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
|
|
G |
Smad4 |
SMAD family member 4 |
|
ISO |
ClinVar Annotator: match by term: Esophageal carcinoma |
ClinVar |
PMID:6604412 PMID:8898652 PMID:9214508 PMID:9285566 PMID:9582123 PMID:9679244 PMID:9811934 PMID:10479724 PMID:10764709 PMID:10775259 PMID:10797267 PMID:11274206 PMID:11583957 PMID:12116240 PMID:12821112 PMID:14715079 PMID:15031030 PMID:15235019 PMID:16613914 PMID:17873119 PMID:17994767 PMID:18823382 PMID:20101697 PMID:20301642 PMID:22316667 PMID:22331366 PMID:25741868 PMID:26572829 PMID:26619011 PMID:26900293 PMID:27595937 PMID:28492532 PMID:31837202 PMID:32300199 PMID:32573726 PMID:32944796 More...
|
|
NCBI chr18:67,243,742...67,274,438
Ensembl chr18:67,243,742...67,274,438
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
treatment |
ISO |
associated with Immune Deficiency Disease, human cells in mouse model |
RGD |
PMID:25724470 |
RGD:127285656 |
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
ClinVar Annotator: match by term: Carcinoma of esophagus | ClinVar Annotator: match by term: Esophageal carcinoma | ClinVar Annotator: match by term: Esophageal carcinoma, somatic |
ClinVar |
PMID:124622 PMID:253702 PMID:960674 PMID:1349175 PMID:1359493 PMID:1565143 PMID:1565144 PMID:1569604 PMID:1591732 PMID:1631137 PMID:1631151 PMID:1673792 PMID:1679237 PMID:1683921 PMID:1686725 PMID:1915267 PMID:1918170 PMID:1978757 PMID:2046748 PMID:2259385 PMID:2531845 PMID:2554494 PMID:2654466 PMID:3784963 PMID:4122735 PMID:6736287 PMID:7478555 PMID:7565304 PMID:7651740 PMID:7707106 PMID:7718482 PMID:7732013 PMID:7737263 PMID:7750099 PMID:7761089 PMID:7783166 PMID:7791795 PMID:7881428 PMID:7885831 PMID:7887414 PMID:8001119 PMID:8023157 PMID:8062826 PMID:8080050 PMID:8099841 PMID:8118819 PMID:8164043 PMID:8242631 PMID:8276238 PMID:8308926 PMID:8336941 PMID:8344492 PMID:8364550 PMID:8401536 PMID:8402598 PMID:8423216 PMID:8425176 PMID:8464896 PMID:8479749 PMID:8527048 PMID:8550239 PMID:8631304 PMID:8633021 PMID:8649776 PMID:8688334 PMID:8718514 PMID:8825920 PMID:8829627 PMID:8843196 PMID:8869100 PMID:9020384 PMID:9049183 PMID:9049184 PMID:9150393 PMID:9157982 PMID:9218725 PMID:9242456 PMID:9290701 PMID:9364015 PMID:9399658 PMID:9399838 PMID:9407971 PMID:9525742 PMID:9546439 PMID:9569050 PMID:9572492 PMID:9598730 PMID:9627118 PMID:9632751 PMID:9635828 PMID:9667734 PMID:9704930 PMID:9825943 PMID:9839505 PMID:9979965 PMID:10089074 PMID:10229196 PMID:10411893 PMID:10519380 PMID:10567903 PMID:10589545 PMID:10616528 PMID:10629033 PMID:10713666 PMID:10732753 PMID:10761705 PMID:10797439 PMID:10864200 PMID:10871862 PMID:10914716 PMID:10922393 PMID:10949938 PMID:11051239 PMID:11051241 PMID:11139324 PMID:11152481 PMID:11180592 PMID:11370630 PMID:11429705 PMID:11479205 PMID:11590071 PMID:11593407 PMID:11782540 PMID:11793474 PMID:11867759 PMID:11896595 PMID:11900253 PMID:11920788 PMID:11920959 PMID:12007217 PMID:12034820 PMID:12124823 PMID:12406399 PMID:12506399 PMID:12509279 PMID:12672316 PMID:12695689 PMID:12700230 PMID:12702523 PMID:12726864 PMID:12792784 PMID:12826609 PMID:12885464 PMID:12901974 PMID:12909720 PMID:12917626 PMID:14559903 PMID:14584079 PMID:14673037 PMID:14743206 PMID:15004724 PMID:15017592 PMID:15037740 PMID:15077194 PMID:15138567 PMID:15221755 PMID:15381368 PMID:15390294 PMID:15541116 PMID:15580553 PMID:15607980 PMID:15607981 PMID:15611505 PMID:15722483 PMID:15781620 PMID:15825182 PMID:15850016 PMID:15925506 PMID:15951970 PMID:15958617 PMID:15982667 PMID:15993273 PMID:16206219 PMID:16209708 PMID:16247456 PMID:16258005 PMID:16288208 PMID:16312222 PMID:16322298 PMID:16337994 PMID:16401470 PMID:16474844 PMID:16489069 PMID:16492679 PMID:16494995 PMID:16508005 PMID:16551709 PMID:16633321 PMID:16682957 PMID:16736287 PMID:16778209 PMID:16793544 PMID:16818505 PMID:16827139 PMID:16861262 PMID:17015838 PMID:17170001 PMID:17308077 PMID:17311302 PMID:17390010 PMID:17401428 PMID:17417627 PMID:17427234 PMID:17530187 PMID:17540308 PMID:17541742 PMID:17567834 PMID:17606709 PMID:17636407 PMID:17724467 PMID:17875924 PMID:17881637 PMID:17974978 PMID:17999388 PMID:18208484 PMID:18453682 PMID:18511570 PMID:18555592 PMID:18628487 PMID:18685109 PMID:18689542 PMID:18818522 PMID:18937320 PMID:18978813 PMID:18989156 PMID:19012332 PMID:19147582 PMID:19171880 PMID:19336573 PMID:19367287 PMID:19367569 PMID:19378321 PMID:19405127 PMID:19454241 PMID:19462533 PMID:19468865 PMID:19556618 PMID:19681600 PMID:19834951 PMID:19850740 PMID:19913028 PMID:19930417 PMID:20013323 PMID:20113312 PMID:20127978 PMID:20128691 PMID:20182602 PMID:20195489 PMID:20308654 PMID:20364130 PMID:20407015 PMID:20505364 PMID:20506564 PMID:20516128 PMID:20522432 PMID:20586629 PMID:20589832 PMID:20693561 PMID:20805372 PMID:20878954 PMID:20972454 PMID:21056685 PMID:21059199 PMID:21080251 PMID:21113594 PMID:21115975 PMID:21159183 PMID:21187651 PMID:21188122 PMID:21232794 PMID:21305319 PMID:21343334 PMID:21356188 PMID:21445056 PMID:21483000 PMID:21484931 PMID:21514416 PMID:21519010 PMID:21522129 PMID:21535297 PMID:21552135 PMID:21590121 PMID:21601526 PMID:21626334 PMID:21674059 PMID:21747090 PMID:21760960 PMID:21760996 PMID:21761402 PMID:22006311 PMID:22052707 PMID:22090360 PMID:22109999 PMID:22110706 PMID:22186996 PMID:22198284 PMID:22233476 PMID:22265402 PMID:22319594 PMID:22427690 PMID:22484423 PMID:22553421 PMID:22672556 PMID:22710932 PMID:22713868 PMID:22768918 PMID:22811390 PMID:22862161 PMID:22887876 PMID:22899716 PMID:22915647 PMID:22919068 PMID:22955915 PMID:22983585 PMID:22999923 PMID:23028800 PMID:23031740 PMID:23124483 PMID:23161690 PMID:23172776 PMID:23246812 PMID:23259501 PMID:23263379 PMID:23264849 PMID:23265383 PMID:23334668 PMID:23340422 PMID:23406775 PMID:23538418 PMID:23612969 PMID:23625637 PMID:23667202 PMID:23713777 PMID:23792586 PMID:23894400 PMID:23939625 PMID:23950206 PMID:23967324 PMID:24033266 PMID:24038938 PMID:24076587 PMID:24122735 PMID:24307375 PMID:24381225 PMID:24384472 PMID:24487413 PMID:24501221 PMID:24549055 PMID:24573247 PMID:24590827 PMID:24603336 PMID:24641375 PMID:24651012 PMID:24651015 PMID:24677579 PMID:24728327 PMID:24744791 PMID:24810334 PMID:24835218 PMID:24857548 PMID:24940547 PMID:25119136 PMID:25157968 PMID:25186627 PMID:25294809 PMID:25339994 PMID:25428789 PMID:25433984 PMID:25503501 PMID:25504633 PMID:25525159 PMID:25584008 PMID:25584637 PMID:25612911 PMID:25619955 PMID:25634208 PMID:25669829 PMID:25691460 PMID:25741868 PMID:25757876 PMID:25787918 PMID:25896519 PMID:25925845 PMID:25927356 PMID:25945745 PMID:25952993 PMID:25961455 PMID:25980754 PMID:26014290 PMID:26022348 PMID:26024390 PMID:26066407 PMID:26205489 PMID:26225655 PMID:26230955 PMID:26270727 PMID:26271412 PMID:26332594 PMID:26425688 PMID:26467025 PMID:26497680 PMID:26554828 PMID:26556299 PMID:26580448 PMID:26585234 PMID:26619011 PMID:26628864 PMID:26655088 PMID:26659639 PMID:26681312 PMID:26781615 PMID:26786923 PMID:26787237 PMID:26818906 PMID:26822237 PMID:26845104 PMID:26878390 PMID:26911350 PMID:26976419 PMID:27022024 PMID:27077130 PMID:27179933 PMID:27189670 PMID:27276561 PMID:27276934 PMID:27328919 PMID:27374712 PMID:27463065 PMID:27489289 PMID:27501770 PMID:27523101 PMID:27533082 PMID:27557517 PMID:27616075 PMID:27621308 PMID:27622479 PMID:27680515 PMID:27683180 PMID:27714481 PMID:27724982 PMID:27813088 PMID:27873457 PMID:27895058 PMID:27959731 PMID:27993330 PMID:28135145 PMID:28152038 PMID:28160093 PMID:28166194 PMID:28271309 PMID:28279309 PMID:28356770 PMID:28369373 PMID:28453743 PMID:28472496 PMID:28477316 PMID:28492532 PMID:28724667 PMID:28772286 PMID:28776571 PMID:28802053 PMID:28861920 PMID:28873162 PMID:28973705 PMID:28975465 PMID:29025599 PMID:29058119 PMID:29070607 PMID:29076966 PMID:29126202 PMID:29300620 PMID:29324801 PMID:29470806 PMID:29478780 PMID:29489754 PMID:29581140 PMID:29666004 PMID:29752822 PMID:29753700 PMID:29875428 PMID:29958926 PMID:29979965 PMID:30076369 PMID:30099178 PMID:30128536 PMID:30216591 PMID:30224644 PMID:30287823 PMID:30299350 PMID:30306255 PMID:30311369 PMID:30318520 PMID:30322717 PMID:30327374 PMID:30352134 PMID:30450585 PMID:30546832 PMID:30583724 PMID:30630526 PMID:30675318 PMID:30709381 PMID:30709875 PMID:30720243 PMID:30730202 PMID:30816478 PMID:30840781 PMID:30918304 PMID:31016814 PMID:31050713 PMID:31081129 PMID:31105275 PMID:31119730 PMID:31121848 PMID:31127191 PMID:31168460 PMID:31206626 PMID:31296311 PMID:31300551 PMID:31494577 PMID:31748977 PMID:31775759 PMID:31882575 PMID:32000721 PMID:32019277 PMID:32126783 PMID:32156018 PMID:32164171 PMID:32179180 PMID:32187361 PMID:32295079 PMID:32318955 PMID:32371905 PMID:32401780 PMID:32475984 PMID:32658383 PMID:32817165 PMID:32888145 PMID:32906206 PMID:32959997 PMID:32980694 PMID:33087929 PMID:33138793 PMID:33163847 PMID:33208383 PMID:33245408 PMID:33257846 PMID:33300245 PMID:33332384 PMID:33372952 PMID:33407742 PMID:33471991 PMID:33633026 PMID:33635883 PMID:33674644 PMID:33758026 PMID:33818021 PMID:33840814 PMID:34240179 PMID:34266904 PMID:34308366 PMID:34529667 PMID:34675114 PMID:34709361 PMID:34793666 PMID:34805717 PMID:34994652 PMID:35033608 PMID:35127508 PMID:35264596 PMID:35820297 PMID:35938033 PMID:35974385 PMID:36219266 PMID:36988593 More...
|
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21332314 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abl1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 |
|
NCBI chr 3:14,979,853...15,083,065
Ensembl chr 3:14,979,853...15,083,065
|
|
G |
Actb |
actin, beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15986332 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Adh7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18500343 |
|
NCBI chr 2:226,748,724...226,763,183
Ensembl chr 2:226,741,788...226,763,182
|
|
G |
Akap13 |
A-kinase anchoring protein 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17068819 |
|
NCBI chr 1:129,313,183...129,619,647
Ensembl chr 1:129,314,402...129,619,646
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8850269 |
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11406566 |
|
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
|
|
G |
Aqp3 |
aquaporin 3 (Gill blood group) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21401805 |
|
NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17634542 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bbc3 |
Bcl-2 binding component 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16481741 |
|
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 |
|
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2a1 |
BCL2-related protein A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17634542 |
|
NCBI chr 8:89,716,914...89,724,998
Ensembl chr 8:89,716,914...89,724,998
|
|
G |
Bsg |
basigin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:36574092 |
|
NCBI chr 7:9,993,170...10,000,387
Ensembl chr 7:9,993,170...10,000,387
|
|
G |
Casp8 |
caspase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17450141 PMID:21472143 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Ccnd1 |
cyclin D1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12235107 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnh |
cyclin H |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30705370 |
|
NCBI chr 2:15,835,064...15,855,648
Ensembl chr 2:15,834,833...15,855,819
|
|
G |
Cdh13 |
cadherin 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18729198 |
|
NCBI chr19:46,349,562...47,387,462
Ensembl chr19:46,349,430...47,387,459
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
disease_progression |
ISO |
|
RGD |
PMID:11903577 |
RGD:8662379 |
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
IEP ISO |
Protein:decreased expression:esophagus CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:18410530 PMID:10969811 |
RGD:1600828 |
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cryab |
crystallin, alpha B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15986332 |
|
NCBI chr 8:51,093,441...51,099,161
Ensembl chr 8:51,093,441...51,099,157
|
|
G |
Csf3 |
colony stimulating factor 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:7692001 |
|
NCBI chr10:83,660,787...83,664,569
Ensembl chr10:83,661,207...83,663,603
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21509778 |
|
NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 |
|
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18059332 |
|
NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204
|
|
G |
Dcc |
DCC netrin 1 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
|
|
NCBI chr18:64,868,987...65,972,783
Ensembl chr18:64,873,898...65,972,740
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21298351 PMID:21468131 PMID:22042947 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Eno1 |
enolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15986332 |
|
NCBI chr 5:160,719,951...160,731,337
Ensembl chr 5:160,719,951...160,731,336 Ensembl chr 3:160,719,951...160,731,336
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22042947 |
|
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
protein:decreased expression:esophageal mucosa: |
RGD |
PMID:9605741 |
RGD:11049151 |
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Faslg |
Fas ligand |
|
ISO |
protein:increased expression:esophageal mucosa: |
RGD |
PMID:9605741 |
RGD:11049151 |
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15986332 |
|
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 |
|
NCBI chr 4:146,865,712...146,869,621
Ensembl chr 4:146,865,712...146,869,621
|
|
G |
Gng7 |
G protein subunit gamma 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18219292 |
|
NCBI chr 7:8,697,458...8,761,239
Ensembl chr 7:8,697,521...8,761,240
|
|
G |
Grik2 |
glutamate ionotropic receptor kainate type subunit 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30705370 |
|
NCBI chr20:52,135,325...52,833,061
Ensembl chr20:52,133,851...52,838,375
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
susceptibility |
ISO |
DNA:deletion: : |
RGD |
PMID:15526353 |
RGD:5490562 |
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Kdr |
kinase insert domain receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 PMID:35917945 |
|
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Lgals3 |
galectin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17634542 |
|
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
|
|
G |
Lzts1 |
leucine zipper tumor suppressor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
|
|
NCBI chr16:20,542,756...20,598,204
Ensembl chr16:20,542,809...20,598,203
|
|
G |
Macir |
macrophage immunometabolism regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30705370 |
|
NCBI chr 9:98,420,760...98,440,818
Ensembl chr 9:98,420,376...98,441,733
|
|
G |
Map3k3 |
mitogen activated protein kinase kinase kinase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17068819 |
|
NCBI chr10:91,020,174...91,088,852
Ensembl chr10:91,020,174...91,088,848
|
|
G |
Marchf8 |
membrane associated ring-CH-type finger 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17068819 |
|
NCBI chr 4:149,415,642...149,530,771
Ensembl chr 4:149,416,071...149,530,770
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22042947 |
|
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
|
|
G |
Mir145 |
microRNA 145 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21248297 |
|
NCBI chr18:55,099,640...55,099,727
Ensembl chr18:55,099,640...55,099,727
|
|
G |
Mir200c |
microRNA 200c |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21248297 |
|
NCBI chr 4:157,523,679...157,523,747
|
|
G |
Mir21 |
microRNA 21 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21248297 |
|
NCBI chr10:71,902,600...71,902,691
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mir98 |
microRNA 98 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27270317 |
|
NCBI chr X:20,981,235...20,981,342
Ensembl chr X:20,981,235...20,981,342
|
|
G |
Mlh3 |
mutL homolog 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16981255 |
|
NCBI chr 6:104,881,483...104,917,686
Ensembl chr 6:104,881,483...104,917,728
|
|
G |
Mmp14 |
matrix metallopeptidase 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 |
|
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
treatment |
IDA |
|
RGD |
PMID:22844359 |
RGD:7207890 |
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15264214 |
|
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nos3 |
nitric oxide synthase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21977915 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Phb1 |
prohibitin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15986332 |
|
NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042
|
|
G |
Prdx1 |
peroxiredoxin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15986332 |
|
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
|
|
G |
Prdx2 |
peroxiredoxin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15986332 |
|
NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12189197 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
susceptibility |
ISO IEP |
DNA:SNPs: :-1195A > G, -765G > C (human) CTD Direct Evidence: marker/mechanism mRNA,protein:increased expression:Esophagus |
CTD RGD |
PMID:11059772 PMID:16322294 PMID:17707579 PMID:16083713 PMID:22165968 |
RGD:5135528, RGD:5687745 |
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rnf6 |
ring finger protein 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
|
|
NCBI chr12:8,816,797...8,826,870
Ensembl chr12:8,816,833...8,826,847
|
|
G |
Rprm |
reprimo, TP53 dependent G2 arrest mediator homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17121882 |
|
NCBI chr 3:38,539,581...38,540,998
Ensembl chr 3:38,539,581...38,540,998
|
|
G |
Runx3 |
RUNX family transcription factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18058463 |
|
NCBI chr 5:147,360,587...147,419,161
Ensembl chr 5:147,360,994...147,419,156
|
|
G |
Serpinb3 |
serpin family B member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15986332 |
|
NCBI chr13:23,274,120...23,280,660
Ensembl chr13:23,274,484...23,313,682
|
|
G |
Sfn |
stratifin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15986332 |
|
NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314
|
|
G |
Slc30a7 |
solute carrier family 30 member 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17068819 |
|
NCBI chr 2:203,855,484...203,922,155
Ensembl chr 2:203,859,175...203,922,132
|
|
G |
Smyd2 |
SET and MYND domain containing 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25825497 |
|
NCBI chr13:101,425,270...101,466,576
Ensembl chr13:101,425,273...101,466,576
|
|
G |
Snai2 |
snail family transcriptional repressor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17068819 |
|
NCBI chr11:86,182,788...86,186,203
Ensembl chr11:86,181,909...86,186,200
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11053990 PMID:15986332 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sst |
somatostatin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17999418 |
|
NCBI chr11:76,956,896...76,958,173
Ensembl chr11:76,956,896...76,958,173
|
|
G |
Tgfbr2 |
transforming growth factor, beta receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10789724 |
|
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
|
|
G |
Tgm2 |
transglutaminase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17068819 |
|
NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981
|
|
G |
Tnfrsf10b |
TNF receptor superfamily member 10b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21472143 |
|
NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:increased expression:esophageal mucosa: |
CTD RGD |
PMID:12706858 PMID:17634542 PMID:26192916 PMID:16778087 PMID:26439224 |
RGD:8547873, RGD:11075085 |
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tpm1 |
tropomyosin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15986332 |
|
NCBI chr 8:67,635,479...67,662,330
Ensembl chr 8:67,635,479...67,662,802
|
|
G |
Tpm4 |
tropomyosin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15986332 |
|
NCBI chr16:17,684,415...17,698,456
Ensembl chr16:17,683,195...17,705,984
|
|
G |
Trmt11 |
tRNA methyltransferase 11 homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30705370 |
|
NCBI chr 1:27,054,437...27,109,765
Ensembl chr 1:27,054,420...27,201,610
|
|
G |
Tufm |
Tu translation elongation factor, mitochondrial |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15986332 |
|
NCBI chr 1:181,073,788...181,077,395
Ensembl chr 1:181,073,788...181,077,395
|
|
G |
Uchl1 |
ubiquitin C-terminal hydrolase L1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15930319 |
|
NCBI chr14:41,485,031...41,495,590
Ensembl chr14:41,485,031...41,495,590
|
|
G |
Wif1 |
Wnt inhibitory factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17384664 |
|
NCBI chr 7:56,548,060...56,618,364
Ensembl chr 7:56,548,053...56,618,360
|
|
G |
Wwox |
WW domain-containing oxidoreductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
|
|
NCBI chr19:42,432,141...43,360,278
Ensembl chr19:42,432,152...43,359,391
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17611394 |
|
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
|
|
G |
Xrcc3 |
X-ray repair cross complementing 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21347786 |
|
NCBI chr 6:130,863,405...130,873,765
Ensembl chr 6:130,863,959...130,872,444
|
|
|
G |
Abl1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
onset |
ISO |
DNA:SNP:3'utr: (rs4740363) (human) |
RGD |
PMID:21472143 |
RGD:126925218 |
NCBI chr 3:14,979,853...15,083,065
Ensembl chr 3:14,979,853...15,083,065
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:23525077 PMID:31906887 |
RGD:127285649 |
NCBI chr 5:145,908,173...145,981,552
Ensembl chr 5:145,908,181...145,985,564
|
|
G |
Barx1 |
BARX homeobox 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24121790 |
|
NCBI chr17:15,990,412...15,993,887
Ensembl chr17:15,990,412...15,993,887
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
onset |
ISO |
DNA:SNPs:3'utr: (rs720321, rs17757541) (human) |
RGD |
PMID:21472143 |
RGD:126925218 |
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Becn1 |
beclin 1 |
|
IEP |
|
RGD |
PMID:22301112 |
RGD:11561943 |
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
treatment |
ISO |
|
RGD |
PMID:26291056 |
RGD:152999007 |
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Casp8 |
caspase 8 |
onset |
ISO |
DNA:SNP:5'utr: (rs1035142) (human) |
RGD |
PMID:21472143 |
RGD:126925218 |
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Cdc5l |
cell division cycle 5-like |
disease_progression |
ISO |
protein:increased expression:esophageal mucosa (human) |
RGD |
PMID:15725809 |
RGD:10047052 |
NCBI chr 9:15,564,949...15,603,453
Ensembl chr 9:15,564,767...15,603,450
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23525077 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Crtc1 |
CREB regulated transcription coactivator 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24121790 |
|
NCBI chr16:18,988,197...19,046,914
Ensembl chr16:18,988,250...19,043,381
|
|
G |
Ctsb |
cathepsin B |
|
ISO |
|
RGD |
PMID:9770500 |
RGD:734853 |
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
onset |
ISO |
DNA:SNP:5'utr: (rs2445762) (human) |
RGD |
PMID:21472143 |
RGD:126925218 |
NCBI chr 8:63,449,148...63,476,534
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
treatment |
ISO |
mRNA:increased expression:esophagus (human) |
RGD |
PMID:30187205 |
RGD:151665176 |
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
|
|
G |
Dock2 |
dedicator of cytokinesis 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23525077 |
|
NCBI chr10:18,827,237...19,244,832
Ensembl chr10:18,827,239...19,244,808
|
|
G |
Elmo1 |
engulfment and cell motility 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23525077 |
|
NCBI chr17:44,286,495...44,822,668
Ensembl chr17:44,286,485...44,822,788
|
|
G |
Emx2 |
empty spiracles homeobox 2 |
|
ISO |
protein:decreased expression:esophagus (human) |
RGD |
PMID:31432154 |
RGD:153323302 |
NCBI chr 1:258,626,584...258,633,594
Ensembl chr 1:258,626,584...258,633,594
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
susceptibility |
ISO |
DNA:snps:cds, 3' utr:c.354C>T, c.8092C>A (human) |
RGD |
PMID:18478337 |
RGD:13207314 |
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
associated with Barrett Esophagus;protein:increased expression:esophageal mucosa (human) |
RGD |
PMID:10340890 |
RGD:8662425 |
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Foxa1 |
forkhead box A1 |
|
ISO |
protein:increased expression:esophagus |
RGD |
PMID:12234996 |
RGD:151665758 |
NCBI chr 6:75,099,907...75,136,534
Ensembl chr 6:75,103,503...75,136,188
|
|
G |
Foxp1 |
forkhead box P1 |
|
ISO |
CTD Direct Evidence: marker/mechanism DNA:snps:intron, enhancer:g.70959438A>G, g.70879779A>C (rs9837992, rs2687201) (human) |
CTD RGD |
PMID:24121790 PMID:26383589 |
RGD:11535321 |
NCBI chr 4:131,559,599...132,155,092
Ensembl chr 4:131,564,756...132,112,258
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
onset |
ISO |
DNA:SNP:5'utr: (rs696217) (human) |
RGD |
PMID:21472143 |
RGD:126925218 |
NCBI chr 4:146,865,712...146,869,621
Ensembl chr 4:146,865,712...146,869,621
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
susceptibility |
ISO |
DNA:SNPs:intron: (rs4958872, rs3792797) (human) |
RGD |
PMID:22715394 |
RGD:152995500 |
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Grb7 |
growth factor receptor bound protein 7 |
exacerbates treatment |
ISO |
human cells in a mouse model |
RGD |
PMID:32737994 PMID:31809243 |
RGD:151347656, RGD:151347659 |
NCBI chr10:83,443,387...83,453,057
Ensembl chr10:83,444,004...83,453,052
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
|
ISO |
DNA:deletion:: (human) |
RGD |
PMID:17064856 |
RGD:12792242 |
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
|
ISO |
DNA:deletion:: (human) |
RGD |
PMID:17064856 |
RGD:12792242 |
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Kdr |
kinase insert domain receptor |
onset |
ISO |
DNA:SNP:5'utr: (rs11941492) (human) |
RGD |
PMID:21472143 |
RGD:126925218 |
NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018
|
|
G |
Mir21 |
microRNA 21 |
disease_progression |
ISO |
|
RGD |
PMID:26481465 |
RGD:41404702 |
NCBI chr10:71,902,600...71,902,691
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
susceptibility |
ISO |
DNA:insertion:promoter:g.-1607insG rs1799750 (human) |
RGD |
PMID:19321798 |
RGD:7207058 |
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp12 |
matrix metallopeptidase 12 |
|
ISO |
DNA:snp:promoter:g.-82A>G rs2276109 (human) |
RGD |
PMID:19321798 |
RGD:7207058 |
NCBI chr 8:4,581,785...4,591,687
Ensembl chr 8:4,581,785...4,599,611
|
|
G |
Mmp14 |
matrix metallopeptidase 14 |
onset |
ISO |
DNA:SNP:5'utr: (rs2236302) (human) |
RGD |
PMID:21472143 |
RGD:126925218 |
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
|
ISO |
DNA:insertion:promoter:g.-1613insA rs3025058 (human) |
RGD |
PMID:19321798 |
RGD:7207058 |
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression:esophagus |
RGD |
PMID:25562781 |
RGD:13204790 |
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Nell1 |
neural EGFL like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17452981 |
|
NCBI chr 1:99,709,305...100,573,872
Ensembl chr 1:99,709,793...100,573,860
|
|
G |
Nos3 |
nitric oxide synthase 3 |
onset |
ISO |
DNA:SNP:3'utr: (rs2070744) (human) |
RGD |
PMID:21472143 |
RGD:126925218 |
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Pik3ca |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23525077 |
|
NCBI chr 2:115,175,275...115,249,034
Ensembl chr 2:115,174,984...115,249,032
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
IEP |
mRNA,protein:increased expression:Esophagus |
RGD |
PMID:22165968 |
RGD:5687745 |
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism protein: increased expression: esophagus |
CTD RGD |
PMID:12507933 PMID:12055587 |
RGD:13207437 |
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Slc22a18 |
solute carrier family 22, member 18 |
disease_progression |
ISO |
DNA:hypermethylation: (human) |
RGD |
PMID:23243219 |
RGD:150557426 |
NCBI chr 1:198,670,626...198,694,977
Ensembl chr 1:198,671,731...198,694,975
|
|
G |
Smad4 |
SMAD family member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23525077 PMID:24952744 |
|
NCBI chr18:67,243,742...67,274,438
Ensembl chr18:67,243,742...67,274,438
|
|
G |
Smo |
smoothened, frizzled class receptor |
treatment |
IMP |
|
RGD |
PMID:23108119 |
RGD:150340553 |
NCBI chr 4:58,343,626...58,373,823
Ensembl chr 4:58,343,529...58,373,829
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
IDA |
|
RGD |
PMID:17785574 |
RGD:2317403 |
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Spart |
spartin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23525077 |
|
NCBI chr 2:139,292,630...139,319,248
Ensembl chr 2:139,292,355...139,319,248
|
|
G |
Tlr4 |
toll-like receptor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23525077 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnfrsf10b |
TNF receptor superfamily member 10b |
onset |
ISO |
DNA:SNP:3'utr: (rs11775256) (human) |
RGD |
PMID:21472143 |
RGD:126925218 |
NCBI chr15:44,840,386...44,868,318
Ensembl chr15:44,840,386...44,867,467
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23525077 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Vdr |
vitamin D receptor |
susceptibility disease_progression |
ISO |
DNA:SNPs,haplotype:exon:rs1989969,rs2238135 (human) DNA:amplication: : |
RGD |
PMID:25910066 PMID:24951052 |
RGD:11055189, RGD:13432070 |
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
|
|
|
G |
Krt14 |
keratin 14 |
|
IEP |
protein:increased expression:esophagus |
RGD |
PMID:16140947 |
RGD:1600174 |
NCBI chr10:85,137,786...85,142,054
Ensembl chr10:85,066,802...85,171,799
|
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21206495 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr 9:113,102,632...113,122,500
Ensembl chr 9:113,103,718...113,109,773
|
|
G |
Ajuba |
ajuba LIM protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25151357 |
|
NCBI chr15:28,019,775...28,031,537
Ensembl chr15:28,019,778...28,030,021
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
disease_progression |
ISO |
protein:increased expression:esophagus (human) |
RGD |
PMID:32642408 |
RGD:152995512 |
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16639733 PMID:22960999 |
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Anxa1 |
annexin A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
|
|
G |
Atm |
ATM serine/threonine kinase |
disease_progression |
ISO |
Smoke Inhalation Injury; mRNA:increased expression:esophagus (human) |
RGD |
PMID:17019709 |
RGD:150340713 |
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Atp1b2 |
ATPase Na+/K+ transporting subunit beta 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25129146 |
|
NCBI chr10:54,318,698...54,324,933
Ensembl chr10:54,318,701...54,324,933
|
|
G |
Axin1 |
axin 1 |
disease_progression |
ISO |
protein:decreased expression:esophagus (human) |
RGD |
PMID:12771989 |
RGD:150530473 |
NCBI chr10:15,163,477...15,215,615
Ensembl chr10:15,163,684...15,215,615
|
|
G |
Azgp1 |
alpha-2-glycoprotein 1, zinc-binding |
disease_progression |
ISO |
|
RGD |
PMID:28053542 |
RGD:153350138 |
NCBI chr12:16,930,990...16,939,333
Ensembl chr12:16,931,024...16,939,091
|
|
G |
Azin1 |
antizyme inhibitor 1 |
|
ISO |
|
RGD |
PMID:24302582 |
RGD:14700707 |
NCBI chr 7:69,654,773...69,681,578
Ensembl chr 7:69,654,663...69,681,578
|
|
G |
B2m |
beta-2 microglobulin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
|
|
G |
Blvrb |
biliverdin reductase B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr 1:82,738,646...82,756,312
Ensembl chr 1:82,738,695...82,770,375
|
|
G |
Bmi1 |
BMI1 proto-oncogene, polycomb ring finger |
|
ISO |
|
RGD |
PMID:21165554 |
RGD:126781701 |
NCBI chr17:81,332,175...81,341,625
Ensembl chr17:81,332,214...81,388,690
|
|
G |
Bmp6 |
bone morphogenetic protein 6 |
|
ISO |
protein:increased expression:esophagus |
RGD |
PMID:22364398 |
RGD:7242413 |
NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
|
ISO |
DNA:SNP: :rs799917 (human) |
RGD |
PMID:23749772 |
RGD:126925960 |
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Brca2 |
BRCA2, DNA repair associated |
|
ISO |
DNA:nonsense mutation: :p.K3326X (human) |
RGD |
PMID:21279724 |
RGD:11344913 |
NCBI chr12:59,492...103,789
Ensembl chr12:59,819...100,567
|
|
G |
Bst2 |
bone marrow stromal cell antigen 2 |
disease_progression |
ISO |
|
RGD |
PMID:26832883 |
RGD:14398496 |
NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979
|
|
G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18691855 |
|
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
|
|
G |
Calr |
calreticulin |
ameliorates |
ISO |
CTD Direct Evidence: marker/mechanism human cells in a mouse model |
CTD RGD |
PMID:21517111 PMID:19684620 PMID:23814025 |
RGD:150521703, RGD:150521679 |
NCBI chr19:23,308,525...23,313,420
Ensembl chr19:23,308,351...23,313,414
|
|
G |
Capza1 |
capping actin protein of muscle Z-line subunit alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr 2:192,319,696...192,364,755
Ensembl chr 2:192,319,702...192,364,480
|
|
G |
Car1 |
carbonic anhydrase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr 2:86,829,436...86,872,209
Ensembl chr 2:86,861,897...86,872,208
|
|
G |
Car12 |
carbonic anhydrase 12 |
severity |
ISO |
|
RGD |
PMID:26316888 |
RGD:155226859 |
NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
|
|
G |
Car2 |
carbonic anhydrase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
|
|
G |
Casp8 |
caspase 8 |
exacerbates |
ISO |
mRNA,protein:decreased expression:esophagus squamous epithelium (human) |
RGD |
PMID:31885720 |
RGD:153300949 |
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Cbx8 |
chromobox 8 |
severity |
ISO |
mRNA:increased expression:esophagus: |
RGD |
PMID:25197352 |
RGD:9587436 |
NCBI chr10:104,294,518...104,296,956
Ensembl chr10:104,294,518...104,297,024
|
|
G |
Cchcr1 |
coiled-coil alpha-helical rod protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29379198 |
|
NCBI chr20:3,205,675...3,218,437
Ensembl chr20:3,205,676...3,218,308
|
|
G |
Ccnd1 |
cyclin D1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25151357 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:15375580 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25151357 |
|
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B |
|
ISO |
DNA:SNPs: :rs615552, rs573687 (human) |
RGD |
PMID:23361049 |
RGD:7248756 |
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
|
|
G |
Cfl1 |
cofilin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
|
|
G |
Chrna5 |
cholinergic receptor nicotinic alpha 5 subunit |
susceptibility |
ISO |
DNA:SNP: :rs667282(human) mRNA:increased expression:esophagus (human) |
RGD |
PMID:23844051 PMID:27610024 |
RGD:150524358, RGD:151361143 |
NCBI chr 8:55,369,794...55,398,526
Ensembl chr 8:55,369,794...55,398,146
|
|
G |
Chrna7 |
cholinergic receptor nicotinic alpha 7 subunit |
exacerbates disease_progression |
ISO |
mRNA:increased expression:esophagus (human) |
RGD |
PMID:27610024 PMID:33603170 PMID:33603170 |
RGD:151361143, RGD:151667905, RGD:151667905 |
NCBI chr 1:116,711,559...116,837,269
Ensembl chr 1:116,714,711...116,837,240
|
|
G |
Chrnb4 |
cholinergic receptor nicotinic beta 4 subunit |
|
ISO |
mRNA:increased expression:esophagus (human) |
RGD |
PMID:27610024 |
RGD:151361143 |
NCBI chr 8:55,417,583...55,437,027
Ensembl chr 8:55,418,313...55,437,027
|
|
G |
Clic1 |
chloride intracellular channel 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr20:3,764,867...3,773,711
Ensembl chr20:3,761,461...3,773,712
|
|
G |
Clptm1l |
CLPTM1-like |
susceptibility no_association |
ISO |
DNA:SNP: :rs451360(human) DNA:SNP: :rs401681(human) mRNA:increased expression:esophagus |
RGD |
PMID:26716642 PMID:24386361 PMID:25480402 PMID:25007268 |
RGD:11572962, RGD:150537098, RGD:150530497, RGD:150530488 |
NCBI chr 1:29,667,545...29,683,530
Ensembl chr 1:29,667,545...29,683,530
|
|
G |
Col14a1 |
collagen type XIV alpha 1 chain |
disease_progression |
ISO |
DNA:hypermethylation |
RGD |
PMID:25050929 |
RGD:151665741 |
NCBI chr 7:86,722,093...86,937,215
Ensembl chr 7:86,722,094...86,937,214
|
|
G |
Crabp1 |
cellular retinoic acid binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17438526 |
|
NCBI chr 8:55,138,363...55,159,360
Ensembl chr 8:55,151,285...55,159,360
|
|
G |
Crebbp |
CREB binding protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25151357 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Csf1r |
colony stimulating factor 1 receptor |
|
ISO |
mRNA:decreased expression:esophagus squamous epithelium (human) |
RGD |
PMID:32038997 |
RGD:150524298 |
NCBI chr18:54,546,673...54,590,418
Ensembl chr18:54,546,659...54,590,415
|
|
G |
Cstb |
cystatin B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr20:10,245,462...10,247,505
Ensembl chr20:10,245,462...10,247,526
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
disease_progression |
ISO |
protein:increased expression:esophagus squamous epithelium (human) |
RGD |
PMID:17171785 |
RGD:152023646 |
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
ISO |
|
RGD |
PMID:11860825 |
RGD:14700943 |
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
IEP |
protein:increased expression:esophagus (rat) |
RGD |
PMID:18618592 |
RGD:7829715 |
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp24a1 |
cytochrome P450, family 24, subfamily a, polypeptide 1 |
susceptibility |
ISO |
DNA:SNP:CDS: (rs2296241) (human) |
RGD |
PMID:28362172 |
RGD:151665500 |
NCBI chr 3:159,275,947...159,290,383
Ensembl chr 3:159,275,947...159,290,383
|
|
G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29379198 |
|
NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628
|
|
G |
Dab2ip |
DAB2 interacting protein |
severity |
ISO |
protein:decreased expression:esophagus (human) |
RGD |
PMID:30464518 |
RGD:151665168 |
NCBI chr 3:18,915,290...19,086,282
Ensembl chr 3:18,915,290...19,086,280
|
|
G |
Dcc |
DCC netrin 1 receptor |
|
ISO |
DNA:deletions:multiple (human) |
OMIM RGD |
PMID:8187090 |
RGD:734879 |
NCBI chr18:64,868,987...65,972,783
Ensembl chr18:64,873,898...65,972,740
|
|
G |
Dido1 |
death inducer-obliterator 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30431698 |
|
NCBI chr 3:167,772,535...167,825,894
Ensembl chr 3:167,772,770...167,817,218
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
disease_progression |
ISO |
protein:increased expression:nucleus: |
RGD |
PMID:22213175 |
RGD:9589085 |
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
|
ISO |
protein:increased expression: esophagus |
RGD |
PMID:24789592 |
RGD:152600903 |
NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:46,962,243...47,043,901
|
|
G |
Efnb2 |
ephrin B2 |
severity exacerbates ameliorates |
ISO |
mRNA:increased expression:esophagus squamous epithelium (human) mRNA,protein:increased expression:esophagus squamous epithelium (human) human cells in mouse model |
RGD |
PMID:17611172 PMID:31885720 PMID:29190834 |
RGD:153300947, RGD:153300949, RGD:153300948 |
NCBI chr16:80,783,389...80,827,420
Ensembl chr16:80,783,417...80,824,391
|
|
G |
Egfr |
epidermal growth factor receptor |
severity |
ISO |
protein:increased expression:esophagus (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21947696 PMID:10385363 |
RGD:5131486 |
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Ehmt1 |
euchromatic histone lysine methyltransferase 1 |
disease_progression |
ISO |
protein:increased expression:esophagus: protein:increased expression:esophagus mucosa: |
RGD |
PMID:24649311 PMID:24805087 |
RGD:9589143, RGD:9590071 |
NCBI chr 3:7,580,680...7,729,046
Ensembl chr 3:7,580,683...7,729,007
|
|
G |
Ehmt2 |
euchromatic histone lysine methyltransferase 2 |
disease_progression |
ISO |
protein:increased expression:esophagus mucosa: |
RGD |
PMID:24805087 |
RGD:9590071 |
NCBI chr20:3,919,623...3,936,751
Ensembl chr20:3,919,624...3,941,547
|
|
G |
Ep300 |
E1A binding protein p300 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17965222 PMID:25151357 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Epb41l3 |
erythrocyte membrane protein band 4.1-like 3 |
disease_progression |
ISO |
DNA:hypermethylation |
RGD |
PMID:25050929 |
RGD:151665741 |
NCBI chr 9:109,056,178...109,260,607
Ensembl chr 9:109,016,113...109,260,607
|
|
G |
Ephb4 |
EPH receptor B4 |
exacerbates |
ISO |
mRNA,protein:increased expression:esophagus squamous epithelium (human) |
RGD |
PMID:31885720 |
RGD:153300949 |
NCBI chr12:19,326,411...19,351,667
Ensembl chr12:19,326,427...19,351,314
|
|
G |
Erbb4 |
erb-b2 receptor tyrosine kinase 4 |
susceptibility disease_progression |
ISO |
DNA:SNPs, haplotypes: :rs1595066 and rs16845990 (human) protein:altered localization:nucleus |
RGD |
PMID:24916311 PMID:18000820 |
RGD:126781764, RGD:126781765 |
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
|
|
G |
Ercc1 |
ERCC excision repair 1, endonuclease non-catalytic subunit |
treatment |
ISO |
|
RGD |
PMID:23263828 |
RGD:11252162 |
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
disease_progression |
ISO |
|
RGD |
PMID:25613619 PMID:21165554 |
RGD:126781697, RGD:126781701 |
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
|
|
G |
Fanca |
FA complementation group A |
|
ISO |
DNA:missense mutation: :p.S858R (human) |
RGD |
PMID:21279724 |
RGD:11344913 |
NCBI chr19:51,304,126...51,362,586
Ensembl chr19:51,304,021...51,362,527
|
|
G |
Fap |
fibroblast activation protein, alpha |
|
ISO |
protein:increased expression: esophagus |
RGD |
PMID:24789592 |
RGD:152600903 |
NCBI chr 3:47,138,823...47,207,671
Ensembl chr 3:47,138,813...47,225,545
|
|
G |
Fasn |
fatty acid synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29379198 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fat1 |
FAT atypical cadherin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:decreased expression:esophagus squamous epithelium (human) |
CTD RGD |
PMID:25151357 PMID:29365412 PMID:24590895 |
RGD:151347646, RGD:151347630 |
NCBI chr16:47,177,253...47,296,261
Ensembl chr16:47,177,248...47,296,107
|
|
G |
Fat2 |
FAT atypical cadherin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25151357 |
|
NCBI chr10:39,364,072...39,456,324
Ensembl chr10:39,364,073...39,456,216
|
|
G |
Fat3 |
FAT atypical cadherin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25151357 |
|
NCBI chr 8:12,691,470...13,274,336
Ensembl chr 8:12,694,019...13,273,135
|
|
G |
Fat4 |
FAT atypical cadherin 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25151357 |
|
NCBI chr 2:121,927,266...122,056,700
Ensembl chr 2:121,927,942...122,056,707
|
|
G |
Fbxw7 |
F-box and WD repeat domain containing 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25151357 |
|
NCBI chr 2:170,149,706...170,311,536
Ensembl chr 2:170,149,694...170,309,941
|
|
G |
Fes |
FES proto-oncogene, tyrosine kinase |
exacerbates |
ISO |
DNA:hypermethylation: (human) |
RGD |
PMID:24936140 |
RGD:153323298 |
NCBI chr 1:134,337,698...134,346,934
Ensembl chr 1:134,337,698...134,346,934
|
|
G |
Fgfr4 |
fibroblast growth factor receptor 4 |
treatment |
ISO |
|
RGD |
PMID:25989802 |
RGD:150520041 |
NCBI chr17:9,461,541...9,476,268
Ensembl chr17:9,461,547...9,476,242
|
|
G |
Fkbp1a |
FKBP prolyl isomerase 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:140,040,278...140,060,743
|
|
G |
Foxa1 |
forkhead box A1 |
onset |
ISO |
DNA:SNPs: :rs12894364 C>T, rs2145146 C>A (human) |
RGD |
PMID:27050876 PMID:29788741 |
RGD:151665743, RGD:151665759 |
NCBI chr 6:75,099,907...75,136,534
Ensembl chr 6:75,103,503...75,136,188
|
|
G |
Fubp1 |
far upstream element binding protein 1 |
exacerbates |
ISO |
protein:increased expression:esophagus (human) mRNA:increased expression:esophagus (human) |
RGD |
PMID:26490982 PMID:32481602 |
RGD:151361192, RGD:151361197 |
NCBI chr 2:241,159,481...241,186,591
Ensembl chr 2:241,159,512...241,186,602
|
|
G |
Gdi2 |
GDP dissociation inhibitor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr17:66,649,616...66,676,299
Ensembl chr17:66,649,619...66,676,366
|
|
G |
Glo1 |
glyoxalase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr20:8,663,617...8,681,661
Ensembl chr20:8,662,801...8,681,649
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
disease_progression |
ISO |
DNA:hypermethylation |
RGD |
PMID:30018730 PMID:25050929 |
RGD:151665494, RGD:151665741 |
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Grb7 |
growth factor receptor bound protein 7 |
exacerbates |
ISO |
protein:increased expression:esophagus (human) |
RGD |
PMID:10797316 |
RGD:151347654 |
NCBI chr10:83,443,387...83,453,057
Ensembl chr10:83,444,004...83,453,052
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
no_association |
ISO |
|
RGD |
PMID:11860825 PMID:17916905 PMID:25432134 |
RGD:14700943, RGD:14700982, RGD:14700948 |
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gsto1 |
glutathione S-transferase omega 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr 1:246,721,089...246,731,228
Ensembl chr 1:246,721,221...246,731,468
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
DNA:polymorphism: :p.I105V (human) |
RGD |
PMID:17916905 |
RGD:14700982 |
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:17173682 PMID:25432134 PMID:17916905 |
RGD:14700948, RGD:14700982 |
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
H19 |
H19 imprinted maternally expressed transcript |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:32739445 |
|
NCBI chr 1:197,730,698...197,733,374
Ensembl chr 1:197,730,698...197,733,134
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17201171 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmgb1 |
high mobility group box 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
|
|
G |
Hmgn5 |
high mobility group nucleosome binding domain 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28914995 |
|
NCBI chr X:74,085,871...74,094,488
Ensembl chr X:74,085,875...74,094,441 Ensembl chr 1:74,085,875...74,094,441
|
|
G |
Hoxb7 |
homeo box B7 |
severity |
ISO |
protein:increased expression:esophageal mucosa (human) |
RGD |
PMID:26076456 |
RGD:10402177 |
NCBI chr10:81,252,616...81,256,034
Ensembl chr10:81,252,553...81,256,034
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Htra1 |
HtrA serine peptidase 1 |
exacerbates ameliorates |
ISO |
mRNA,protein:decreased expression:epithelium of esophagus (human) human gene and cells in mouse model |
RGD |
PMID:23079781 PMID:23079781 |
RGD:152975633, RGD:152975633 |
NCBI chr 1:185,497,815...185,547,380
Ensembl chr 1:185,497,735...185,547,379
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
severity |
ISO |
human cells in mouse model |
RGD |
PMID:32367071 |
RGD:149735568 |
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
|
|
G |
Jak2 |
Janus kinase 2 |
severity |
ISO |
protein:increased phosphorylation:esophagus squamous epithelium (human) |
RGD |
PMID:32158193 |
RGD:127285669 |
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
exacerbates |
ISO |
protein:increased expression:esophagus (human) |
RGD |
PMID:30227324 PMID:19758438 |
RGD:151347669, RGD:151347672 |
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Kat2b |
lysine acetyltransferase 2B |
|
ISO |
mRNA:decreased expression:esophagus (human) |
RGD |
PMID:19525977 |
RGD:9590307 |
NCBI chr 9:6,562,525...6,667,064
Ensembl chr 9:6,562,288...6,667,064
|
|
G |
Kdm4c |
lysine demethylase 4C |
severity susceptibility |
ISO |
protein:increased expression:esophageal epithelium, nucleus (human) DNA:snp:intron:IVS8-3292G>A (rs1340513) (human) |
RGD |
PMID:24224128 PMID:15805246 |
RGD:9587746, RGD:9587752 |
NCBI chr 5:88,100,710...88,306,821
Ensembl chr 5:88,100,733...88,306,818
|
|
G |
Kdm5b |
lysine demethylase 5B |
severity |
ISO |
protein:increased expression:esophageal mucosa, cytoplasm (human) |
RGD |
PMID:22534467 |
RGD:9587776 |
NCBI chr13:46,001,589...46,073,868
Ensembl chr13:46,002,542...46,073,872
|
|
G |
Kdm6a |
lysine demethylase 6A |
ameliorates |
ISO |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:esophagus (human) protein:increased expression:esophagus (human) |
CTD RGD |
PMID:25151357 PMID:31804468 PMID:29351209 |
RGD:150429742, RGD:150429739 |
NCBI chr X:4,337,466...4,477,100
Ensembl chr X:4,337,750...4,477,062
|
|
G |
Kmt2c |
lysine methyltransferase 2C |
|
ISO |
DNA:mutations:multiple (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:25151357 PMID:25151357 |
RGD:9588233 |
NCBI chr 4:9,620,638...9,834,787
Ensembl chr 4:9,609,627...9,833,539
|
|
G |
Kmt2d |
lysine methyltransferase 2D |
|
ISO |
DNA:mutations:multiple (human) mRNA:increased expression:esophagus CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:25151357 PMID:25151357 PMID:29532228 |
RGD:9588233, RGD:150521712 |
NCBI chr 7:129,980,744...130,022,088
Ensembl chr 7:129,962,887...130,020,325
|
|
G |
Krt13 |
keratin 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr10:85,051,887...85,056,099
Ensembl chr10:85,051,889...85,056,084
|
|
G |
Krt14 |
keratin 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16543248 |
|
NCBI chr10:85,137,786...85,142,054
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Krt16 |
keratin 16 |
|
IEP |
|
RGD |
PMID:8950218 |
RGD:633113 |
NCBI chr10:85,168,357...85,171,816
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Krt17 |
keratin 17 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr10:85,178,673...85,183,392
Ensembl chr10:85,178,675...85,183,392
|
|
G |
Krt19 |
keratin 19 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr10:85,075,835...85,080,552
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Krt7 |
keratin 7 |
disease_progression |
ISO |
|
RGD |
PMID:29788741 |
RGD:151665759 |
NCBI chr 7:132,528,881...132,545,052
Ensembl chr 7:132,528,895...132,545,052
|
|
G |
Loxl2 |
lysyl oxidase-like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24716982 |
|
NCBI chr15:44,683,449...44,773,067
Ensembl chr15:44,683,880...44,773,067
|
|
G |
Lta |
lymphotoxin alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29379198 |
|
NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,618,853...3,620,859
|
|
G |
Lzts1 |
leucine zipper tumor suppressor 1 |
|
ISO |
ClinVar Annotator: match by term: Esophageal squamous cell carcinoma, somatic | ClinVar Annotator: match by term: LZTS1-related condition |
OMIM ClinVar |
PMID:10097140 PMID:25741868 PMID:26504261 PMID:28492532 |
|
NCBI chr16:20,542,756...20,598,204
Ensembl chr16:20,542,809...20,598,203
|
|
G |
Mad2l1 |
mitotic arrest deficient 2 like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18691855 |
|
NCBI chr 4:95,906,692...95,918,885
Ensembl chr 4:95,906,817...95,913,470
|
|
G |
Map3k1 |
mitogen-activated protein kinase kinase kinase 1 |
sexual_dimorphism |
ISO |
DNA:missense mutation, SNP:CDS, exon 14, 3'-UTR: (rs702689,rs702688) (human) |
RGD |
PMID:32753933 |
RGD:150573717 |
NCBI chr 2:43,348,572...43,414,706
Ensembl chr 2:43,350,098...43,414,463
|
|
G |
Mbd4 |
methyl-CpG binding domain 4 DNA glycosylase |
susceptibility |
ISO |
DNA:snp:cds:p.E346K (rs140693) (human) DNA:snp:intron:IVS5-140A>G (rs3138355) (human) |
RGD |
PMID:15205355 PMID:25162968 |
RGD:9588976, RGD:9588980 |
NCBI chr 4:148,893,049...148,904,833
Ensembl chr 4:148,894,280...148,904,982
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism DNA, protein:hypermethylation, decreased expression:promoter, esophagus |
CTD RGD |
PMID:25520135 PMID:21674174 |
RGD:126790574 |
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Mir10a |
microRNA 10a |
|
ISO |
miRNA:increased expression:esophagus squamous epithelium (human) |
RGD |
PMID:32997362 |
RGD:153323343 |
NCBI chr10:81,283,171...81,283,280
Ensembl chr10:81,283,171...81,283,280
|
|
G |
Mir127 |
microRNA 127 |
|
ISO |
RNA:decreased expression:esophagus (human) |
RGD |
PMID:27645894 |
RGD:152995354 |
NCBI chr 6:128,546,215...128,546,311
Ensembl chr 6:128,546,215...128,546,311
|
|
G |
Mir193a |
microRNA 193a |
exacerbates |
ISO |
miRNA:decreased expression:esophagus (human) |
RGD |
PMID:27203740 |
RGD:153323341 |
NCBI chr10:64,672,343...64,672,454
Ensembl chr10:64,672,343...64,672,454
|
|
G |
Mir217 |
microRNA 217 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25538231 |
|
NCBI chr14:102,531,505...102,531,609
Ensembl chr14:102,531,505...102,531,609
|
|
G |
Mir31 |
microRNA 31 |
ameliorates |
IMP ISO |
|
RGD |
PMID:32123074 PMID:21658006 |
RGD:127285381, RGD:152998938 |
NCBI chr 5:103,599,038...103,599,143
|
|
G |
Mir423 |
microRNA 423 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24205249 |
|
NCBI chr10:61,914,142...61,914,220
Ensembl chr10:61,914,133...61,914,226
|
|
G |
Mir494 |
microRNA 494 |
|
ISO |
mRNA:decreased expression:esophagus |
RGD |
PMID:25480402 |
RGD:150530497 |
NCBI chr 6:128,728,710...128,728,792
Ensembl chr 6:128,728,709...128,728,793
|
|
G |
Mlh1 |
mutL homolog 1 |
disease_progression |
ISO |
DNA, protein:hypermethylation, decreased expression:promoter, esophagus |
RGD |
PMID:21674174 |
RGD:126790574 |
NCBI chr 8:111,196,468...111,233,721
Ensembl chr 8:111,196,468...111,233,617
|
|
G |
Mmp14 |
matrix metallopeptidase 14 |
|
ISO |
protein:increased expression: esophagus |
RGD |
PMID:24789592 |
RGD:152600903 |
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
ISO |
protein:increased activity: esophagus |
RGD |
PMID:24789592 |
RGD:152600903 |
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased activity: esophagus |
RGD |
PMID:24789592 |
RGD:152600903 |
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Msh2 |
mutS homolog 2 |
disease_progression |
ISO |
DNA, protein:hypermethylation, decreased expression:promoter, esophagus DNA, protein:hypermethylation, decreased expression:esophagus |
RGD |
PMID:22265839 PMID:21674174 PMID:24366688 |
RGD:126790560, RGD:126790574, RGD:126790573 |
NCBI chr 6:6,813,793...6,872,960
Ensembl chr 6:6,813,795...6,872,938
|
|
G |
Mt1 |
metallothionein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16543248 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25151357 |
|
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Notch1 |
notch receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25151357 |
|
NCBI chr 3:9,277,955...9,323,531
Ensembl chr 3:9,278,086...9,323,531
|
|
G |
Notch2 |
notch receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25151357 |
|
NCBI chr 2:185,610,594...185,744,088
Ensembl chr 2:185,610,589...185,744,088
|
|
G |
Notch3 |
notch receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25151357 |
|
NCBI chr 7:11,132,984...11,184,025
Ensembl chr 7:11,133,706...11,184,025
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:38467300 |
|
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
|
|
G |
Pagr1 |
Paxip1-associated glutamate-rich protein 1 |
|
ISO |
mRNA, protein:decreased expression:esophagus (human) |
RGD |
PMID:33833989 |
RGD:153344568 |
NCBI chr 1:181,622,698...181,625,024
|
|
G |
Pbx3 |
PBX homeobox 3 |
|
ISO |
RNA:increased expression:esophagus squamous epithelium (human) |
RGD |
PMID:32449803 |
RGD:153345544 |
NCBI chr 3:17,488,691...17,682,412
Ensembl chr 3:17,488,693...17,682,791
|
|
G |
Pfn1 |
profilin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr10:55,365,263...55,367,968
Ensembl chr10:55,365,262...55,527,631
|
|
G |
Plce1 |
phospholipase C, epsilon 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20729852 PMID:20729853 |
|
NCBI chr 1:236,243,445...236,552,571
Ensembl chr 1:236,244,683...236,551,438
|
|
G |
Prdx1 |
peroxiredoxin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
|
|
G |
Psmb9 |
proteasome 20S subunit beta 9 |
disease_progression |
ISO |
|
RGD |
PMID:19492245 |
RGD:6482249 |
NCBI chr20:4,667,044...4,672,512
Ensembl chr20:4,666,046...4,672,512
|
|
G |
Psme1 |
proteasome activator subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr15:29,069,012...29,071,888
Ensembl chr15:29,068,729...29,071,890
|
|
G |
Psme2 |
proteasome activator subunit 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr15:29,078,495...29,082,794
Ensembl chr15:29,078,500...29,082,946
|
|
G |
Ptch1 |
patched 1 |
disease_progression |
ISO |
|
RGD |
PMID:16475698 |
RGD:150523841 |
NCBI chr17:1,542,705...1,607,730
Ensembl chr17:1,542,877...1,607,333
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15756444 PMID:16543248 PMID:18197933 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptprt |
protein tyrosine phosphatase, receptor type, T |
susceptibility |
ISO |
DNA:SNPs:3'utr: (rs2866943 , rs6029959 ) (human) |
RGD |
PMID:25967969 |
RGD:150520191 |
NCBI chr 3:150,189,343...151,288,145
Ensembl chr 3:150,194,859...151,288,124
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25151357 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rictor |
RPTOR independent companion of MTOR, complex 2 |
disease_progression severity |
ISO |
human cells in mouse model protein:increased expression:esophagus (human) |
RGD |
PMID:30119206 PMID:32642408 PMID:28132115 |
RGD:152995460, RGD:152995512, RGD:152995470 |
NCBI chr 2:55,811,877...55,903,893
Ensembl chr 2:55,811,322...55,901,426
|
|
G |
Rnf6 |
ring finger protein 6 |
|
ISO |
ClinVar Annotator: match by term: Esophageal squamous cell carcinoma, somatic |
ClinVar OMIM |
PMID:12154016 |
|
NCBI chr12:8,816,797...8,826,870
Ensembl chr12:8,816,833...8,826,847
|
|
G |
Runx1 |
RUNX family transcription factor 1 |
|
ISO |
DNA:SNP: :rs2014300 (human) |
RGD |
PMID:30666517 |
RGD:126775149 |
NCBI chr11:31,839,880...32,074,427
Ensembl chr11:31,843,764...32,074,542
|
|
G |
Runx2 |
RUNX family transcription factor 2 |
|
ISO |
mRNA:increased expression:esophagus mucosa |
RGD |
PMID:18500170 |
RGD:126779568 |
NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:16,167,482...16,492,167
|
|
G |
Runx3 |
RUNX family transcription factor 3 |
disease_progression |
ISO |
mRNA:decreased expression:esophagus mucosa |
RGD |
PMID:18500170 |
RGD:126779568 |
NCBI chr 5:147,360,587...147,419,161
Ensembl chr 5:147,360,994...147,419,156
|
|
G |
Sall4 |
spalt-like transcription factor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30431698 |
|
NCBI chr 3:157,474,067...157,491,055
Ensembl chr 3:157,474,642...157,490,822
|
|
G |
Serpinb3 |
serpin family B member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr13:23,274,120...23,280,660
Ensembl chr13:23,274,484...23,313,682
|
|
G |
Setd5 |
SET domain containing 5 |
disease_progression |
ISO |
|
RGD |
PMID:31981592 |
RGD:155804254 |
NCBI chr 4:146,217,172...146,294,896
Ensembl chr 4:146,217,180...146,294,894
|
|
G |
Sfn |
stratifin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314
|
|
G |
Slc16a10 |
solute carrier family 16 member 10 |
|
ISO |
protein:increased expression:esophagus |
RGD |
PMID:33609949 |
RGD:151361149 |
NCBI chr20:43,454,819...43,567,839
Ensembl chr20:43,459,709...43,567,839
|
|
G |
Slc1a5 |
solute carrier family 1 member 5 |
disease_progression |
ISO |
protein:increased expression:esophagus |
RGD |
PMID:33609949 PMID:26936531 |
RGD:151361149, RGD:11532833 |
NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:77,456,694...77,470,952
|
|
G |
Slc39a6 |
solute carrier family 39 member 6 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:23644492 |
|
NCBI chr18:15,864,874...15,885,417
Ensembl chr18:15,864,875...15,885,417
|
|
G |
Slc52a3 |
solute carrier family 52 member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20729853 |
|
NCBI chr 3:140,498,924...140,515,845
Ensembl chr 3:140,509,473...140,514,096
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
disease_progression |
ISO |
protein:increased expression:esophagus |
RGD |
PMID:31726270 PMID:26936531 PMID:33609949 |
RGD:151361144, RGD:11532833, RGD:151361149 |
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
severity treatment |
ISO |
mRNA:decreased expression:esophagus |
RGD |
PMID:21385099 PMID:31728180 PMID:28233302 |
RGD:150573691, RGD:150573815, RGD:150573812 |
NCBI chr10:4,882,651...4,884,342
Ensembl chr10:4,882,560...4,884,383
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18167182 PMID:21517111 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sox2 |
SRY-box transcription factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19801978 |
|
NCBI chr 2:117,536,929...117,539,340
Ensembl chr 2:117,536,929...117,539,338
|
|
G |
Spen |
spen family transcriptional repressor |
|
ISO |
associated with Neoplasm Metastasis; DNA:mutations |
RGD |
PMID:33363385 |
RGD:151347445 |
NCBI chr 5:153,775,287...153,848,677
Ensembl chr 5:153,776,234...153,848,811
|
|
G |
Stim1 |
stromal interaction molecule 1 |
exacerbates |
ISO |
protein:increased expression:esophagus (human) |
RGD |
PMID:31843504 |
RGD:152995393 |
NCBI chr 1:156,656,246...156,818,777
Ensembl chr 1:156,656,013...156,818,363
|
|
G |
Sting1 |
stimulator of interferon response cGAMP interactor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25129146 |
|
NCBI chr18:27,332,119...27,338,371
Ensembl chr18:27,332,119...27,338,335
|
|
G |
Sult1a1 |
sulfotransferase family 1A member 1 |
|
ISO |
DNA:SNP:exon:p.R213H, 638G>A (human) |
RGD |
PMID:12455060 |
RGD:1581448 |
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
|
|
G |
Tagln |
transgelin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668
|
|
G |
Tap1 |
transporter 1, ATP binding cassette subfamily B member |
|
ISO |
protein:decreased expression:esophagus |
RGD |
PMID:19492245 |
RGD:6482249 |
NCBI chr20:4,656,262...4,666,634
Ensembl chr20:4,656,263...4,666,901
|
|
G |
Tap2 |
transporter 2, ATP binding cassette subfamily B member |
|
ISO |
protein:decreased expression:esophagus |
RGD |
PMID:19492245 |
RGD:6482249 |
NCBI chr20:4,636,347...4,650,387
Ensembl chr20:4,636,357...4,650,407
|
|
G |
Tcn2 |
transcobalamin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29379198 |
|
NCBI chr14:78,813,343...78,828,549
Ensembl chr14:78,813,343...78,828,489
|
|
G |
Tert |
telomerase reverse transcriptase |
susceptibility no_association |
ISO |
DNA:SNPs: : rs2853691,rs2736100(human) mRNA:increased expression:esophagus squamous epithelium: DNA:SNP: :rs2736098(human) |
RGD |
PMID:26716642 PMID:15112252 PMID:25007268 |
RGD:11572962, RGD:152977757, RGD:150530488 |
NCBI chr 1:29,637,213...29,659,561
Ensembl chr 1:29,637,506...29,659,561
|
|
G |
Tet2 |
tet methylcytosine dioxygenase 2 |
severity |
ISO |
mRNA:decreased expression:esophagus squamous epithelium (human) associated with Lymphatic Metastasis;mRNA:decreased expression:esophagus squamous epithelium (human) DNA:mutations |
RGD |
PMID:26093090 PMID:27050164 PMID:26873401 |
RGD:11528815, RGD:150429668, RGD:150429656 |
NCBI chr 2:221,988,645...222,072,813
Ensembl chr 2:221,988,645...222,072,534
|
|
G |
Tet3 |
tet methylcytosine dioxygenase 3 |
|
ISO |
mRNA:decreased expression:esophagus squamous epithelium (human) |
RGD |
PMID:27050164 |
RGD:150429668 |
NCBI chr 4:115,867,412...115,964,433
Ensembl chr 4:115,871,265...115,964,193
|
|
G |
Tgfbr2 |
transforming growth factor, beta receptor 2 |
|
ISO |
|
OMIM |
|
|
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
severity |
ISO |
mRNA,protein:increased expression:esophagus squamous epithelium (human) |
RGD |
PMID:28197630 |
RGD:151347617 |
NCBI chr 1:13,709,211...13,724,291
Ensembl chr 1:13,709,206...13,725,282
|
|
G |
Tnfaip8 |
TNF alpha induced protein 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21969086 |
|
NCBI chr18:43,183,854...43,299,512
Ensembl chr18:43,183,916...43,299,517
|
|
G |
Tnxb |
tenascin XB |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29379198 |
|
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
DNA:misssense mutation: :p.R72P (rs1042522) (human) CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:16543248 PMID:25151357 PMID:28789369 |
RGD:14995932 |
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tpi1 |
triosephosphate isomerase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr 4:157,615,283...157,618,813
Ensembl chr 4:157,615,386...157,619,541
|
|
G |
Tpm1 |
tropomyosin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr 8:67,635,479...67,662,330
Ensembl chr 8:67,635,479...67,662,802
|
|
G |
Tpm2 |
tropomyosin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr 5:57,770,919...57,780,278
Ensembl chr 5:57,770,864...57,779,992
|
|
G |
Txndc17 |
thioredoxin domain containing 17 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21517111 |
|
NCBI chr10:56,832,749...56,835,721
|
|
G |
Tymp |
thymidine phosphorylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11641616 |
|
NCBI chr 7:120,438,768...120,444,088
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
|
|
G |
Usp8 |
ubiquitin specific peptidase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:35022897 |
|
NCBI chr 3:113,962,136...114,009,683
Ensembl chr 3:113,962,164...114,009,666
|
|
G |
Uty |
ubiquitously transcribed tetratricopeptide repeat containing, Y-linked |
|
ISO |
DNA:mutations:multiple (human) |
RGD |
PMID:25151357 |
RGD:9588233 |
NCBI chr Y:942,838...1,105,313
Ensembl chr Y:924,168...1,103,422
|
|
G |
Ventx |
VENT homeobox |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30431698 |
|
NCBI chr X:86,483,893...86,484,900
Ensembl chr X:86,483,893...86,484,954
|
|
G |
Wrap53 |
WD repeat containing, antisense to TP53 |
disease_progression |
ISO |
|
RGD |
PMID:24626331 |
RGD:21081532 |
NCBI chr10:54,282,092...54,299,908
Ensembl chr10:54,282,105...54,298,929
|
|
G |
Wwox |
WW domain-containing oxidoreductase |
|
ISO |
esophageal squamous cell carcinoma, OMIM:133239 ClinVar Annotator: match by term: Esophageal squamous cell carcinoma | ClinVar Annotator: match by term: Esophageal squamous cell carcinoma, somatic CTD Direct Evidence: marker/mechanism |
ClinVar OMIM CTD RGD |
PMID:11956080 PMID:16199547 PMID:24456803 PMID:25411445 PMID:25526675 PMID:25558065 PMID:25741868 PMID:27717089 PMID:28492532 PMID:29852413 PMID:11956080 More...
|
RGD:1599874 |
NCBI chr19:42,432,141...43,360,278
Ensembl chr19:42,432,152...43,359,391
|
|
G |
Xpo1 |
exportin 1 |
exacerbates |
ISO |
mRNA, protein:increased expression:epithelium of esophagus (human) protein:increased expression:esophagus (human) |
RGD |
PMID:24898882 PMID:25148895 |
RGD:151667431, RGD:151667436 |
NCBI chr14:97,233,282...97,275,536
Ensembl chr14:97,233,270...97,275,498
|
|
G |
Xrcc1 |
X-ray repair cross complementing 1 |
no_association susceptibility treatment |
ISO |
CTD Direct Evidence: marker/mechanism DNA:missense mutation:cds: p.R399Q (human) DNA:SNPs,haplotypes:multiple (human) DNA:SNPs:exon 6, exon 9, exon 10:multiple (human) |
CTD RGD |
PMID:16639733 PMID:11400117 PMID:25710005 PMID:27123143 PMID:28356949 |
RGD:151347444, RGD:150530501, RGD:150530634, RGD:150530505 |
NCBI chr 1:80,140,495...80,168,705
Ensembl chr 1:80,141,207...80,168,701
|
|
G |
Zcchc12 |
zinc finger CCHC-type containing 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30431698 |
|
NCBI chr X:115,433,444...115,436,691
Ensembl chr X:115,433,259...115,436,692
|
|
|
G |
Cdc73 |
cell division cycle 73 |
|
ISO |
ClinVar Annotator: match by term: Cystic parathyroid adenoma |
ClinVar |
PMID:12434154 |
|
NCBI chr13:55,357,226...55,449,690
Ensembl chr13:55,357,226...55,449,656
|
|
|
G |
Insrr |
insulin receptor-related receptor |
|
ISO |
ClinVar Annotator: match by term: Familial medullary thyroid carcinoma |
ClinVar |
PMID:25741868 |
|
NCBI chr 2:173,255,335...173,274,800
Ensembl chr 2:173,255,414...173,274,800
|
|
G |
Ntrk1 |
neurotrophic receptor tyrosine kinase 1 |
|
ISO |
ClinVar Annotator: match by term: Familial medullary thyroid carcinoma | ClinVar Annotator: match by term: Thyroid cancer, familial medullary |
ClinVar |
PMID:10330344 PMID:10443680 PMID:10861667 PMID:11139246 PMID:11159935 PMID:11719521 PMID:20301726 PMID:25741868 PMID:26467025 PMID:28492532 More...
|
|
NCBI chr 2:173,236,961...173,253,806
Ensembl chr 2:173,236,963...173,253,770
|
|
G |
Prlr |
prolactin receptor |
|
ISS |
OMIM:155240 |
MouseDO |
|
|
NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:59,134,588...59,324,718
|
|
G |
Ret |
ret proto-oncogene |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Familial medullary thyroid carcinoma | ClinVar Annotator: match by term: Thyroid cancer, familial medullary |
CTD ClinVar OMIM |
PMID:2660074 PMID:3078962 PMID:3697657 PMID:7536460 PMID:7595170 PMID:7633441 PMID:7647787 PMID:7716719 PMID:7784092 PMID:7824936 PMID:7835899 PMID:7845675 PMID:7849720 PMID:7874109 PMID:7881414 PMID:7906417 PMID:7906866 PMID:7907913 PMID:7911697 PMID:7915165 PMID:7915166 PMID:7977365 PMID:8099202 PMID:8103403 PMID:8114940 PMID:8557249 PMID:8570194 PMID:8595427 PMID:8626834 PMID:8675603 PMID:8733882 PMID:8782503 PMID:8797874 PMID:8807338 PMID:8855832 PMID:8909322 PMID:8918855 PMID:9067749 PMID:9090527 PMID:9111992 PMID:9111993 PMID:9146685 PMID:9174404 PMID:9230192 PMID:9242375 PMID:9259198 PMID:9263528 PMID:9384613 PMID:9398735 PMID:9452077 PMID:9467562 PMID:9498388 PMID:9506724 PMID:9606292 PMID:9620546 PMID:9681851 PMID:9681852 PMID:9727738 PMID:9745455 PMID:9760196 PMID:9824583 PMID:9839497 PMID:9868860 PMID:9879991 PMID:9950371 PMID:10024437 PMID:10076558 PMID:10220148 PMID:10235148 PMID:10323403 PMID:10369718 PMID:10445857 PMID:10462620 PMID:10490816 PMID:10549772 PMID:10646792 PMID:10679286 PMID:10777380 PMID:10790203 PMID:10826520 PMID:10876191 PMID:10982477 PMID:11114642 PMID:11230481 PMID:11238493 PMID:11351254 PMID:11386462 PMID:11436122 PMID:11454140 PMID:11471675 PMID:11562352 PMID:11589684 PMID:11688458 PMID:11732489 PMID:11739416 PMID:11788682 PMID:11849247 PMID:11932300 PMID:11935126 PMID:11939755 PMID:12000816 PMID:12019403 PMID:12116277 PMID:12150334 PMID:12193298 PMID:12409662 PMID:12410354 PMID:12490841 PMID:12566528 PMID:12686527 PMID:12694233 PMID:12788868 PMID:12864791 PMID:12920219 PMID:14517954 PMID:14561794 PMID:14566559 PMID:14602786 PMID:14633923 PMID:14715928 PMID:14718397 PMID:15184865 PMID:15240641 PMID:15277225 PMID:15292360 PMID:15331579 PMID:15345114 PMID:15386323 PMID:15531714 PMID:15588376 PMID:15588381 PMID:15699703 PMID:15741265 PMID:15753368 PMID:15771139 PMID:15834508 PMID:15844786 PMID:15855933 PMID:15858153 PMID:15870131 PMID:15991157 PMID:16118333 PMID:16275981 PMID:16314641 PMID:16325365 PMID:16343097 PMID:16384843 PMID:16441254 PMID:16469774 PMID:16507829 PMID:16525712 PMID:16532227 PMID:16649977 PMID:16705552 PMID:16707008 PMID:16712668 PMID:16715139 PMID:16736292 PMID:16813623 PMID:16849421 PMID:16865646 PMID:16865647 PMID:16868135 PMID:16928683 PMID:17021738 PMID:17032739 PMID:17047083 PMID:17097365 PMID:17108110 PMID:17178962 PMID:17188172 PMID:17209045 PMID:17316110 PMID:17384210 PMID:17466010 PMID:17483988 PMID:17540634 PMID:17590169 PMID:17605401 PMID:17610518 PMID:17664273 PMID:17704047 PMID:17895320 PMID:17963006 PMID:18058472 PMID:18062802 PMID:18063059 PMID:18073307 PMID:18206480 PMID:18209889 PMID:18248648 PMID:18252215 PMID:18299477 PMID:18805915 PMID:18984779 PMID:19041016 PMID:19169500 PMID:19201392 PMID:19445625 PMID:19469690 PMID:19472011 PMID:19826964 PMID:19906784 PMID:19958926 PMID:20039896 PMID:20041006 PMID:20080836 PMID:20087666 PMID:20103606 PMID:20142552 PMID:20369307 PMID:20442138 PMID:20494215 PMID:20497437 PMID:20516206 PMID:20554711 PMID:20719260 PMID:20739875 PMID:20833330 PMID:20979234 PMID:20981092 PMID:21054478 PMID:21134561 PMID:21253810 PMID:21254918 PMID:21309721 PMID:21311890 PMID:21422799 PMID:21454698 PMID:21479187 PMID:21490379 PMID:21626080 PMID:21655256 PMID:21678021 PMID:21688339 PMID:21690267 PMID:21711375 PMID:21765987 PMID:21810974 PMID:21834681 PMID:21986619 PMID:21995290 PMID:22068382 PMID:22174939 PMID:22199277 PMID:22233172 PMID:22270996 PMID:22359510 PMID:22403753 PMID:22584710 PMID:22584715 PMID:22676047 PMID:22676344 PMID:22703879 PMID:22729463 PMID:22747440 PMID:22811860 PMID:22837065 PMID:22865907 PMID:22965292 PMID:22992277 PMID:22995991 PMID:23084198 PMID:23210566 PMID:23278115 PMID:23295303 PMID:23341727 PMID:23461807 PMID:23468374 PMID:23514012 PMID:23526464 PMID:23527089 PMID:23660872 PMID:23723040 PMID:23744765 PMID:23745650 PMID:23756355 PMID:24033266 PMID:24064755 PMID:24144365 PMID:24152999 PMID:24331334 PMID:24336963 PMID:24361808 PMID:24375508 PMID:24449023 PMID:24560924 PMID:24569963 PMID:24616773 PMID:24617864 PMID:24684035 PMID:24699901 PMID:24716929 PMID:24728327 PMID:24794695 PMID:24805091 PMID:24845513 PMID:25319874 PMID:25349307 PMID:25374962 PMID:25425582 PMID:25440022 PMID:25497412 PMID:25501606 PMID:25624014 PMID:25628771 PMID:25637381 PMID:25694125 PMID:25733075 PMID:25741868 PMID:25759805 PMID:25767701 PMID:25810047 PMID:25887804 PMID:25903693 PMID:26033033 PMID:26046350 PMID:26084817 PMID:26230854 PMID:26247112 PMID:26254625 PMID:26269449 PMID:26343384 PMID:26356818 PMID:26395553 PMID:26467025 PMID:26678667 PMID:26687385 PMID:26758973 PMID:26845104 PMID:26920351 PMID:27099842 PMID:27153395 PMID:27207748 PMID:27379493 PMID:27539324 PMID:27673361 PMID:27807060 PMID:27809725 PMID:27884173 PMID:27994876 PMID:28125075 PMID:28137737 PMID:28323957 PMID:28492532 PMID:28647780 PMID:28873162 PMID:28946813 PMID:28951487 PMID:29026273 PMID:29097883 PMID:29192238 PMID:29396759 PMID:29408964 PMID:29420094 PMID:29549836 PMID:29579362 PMID:29590403 PMID:29625052 PMID:29641532 PMID:29656518 PMID:29684080 PMID:29790872 PMID:30172768 PMID:30217742 PMID:30392857 PMID:30644554 PMID:30660595 PMID:30763276 PMID:30877234 PMID:30884088 PMID:30927507 PMID:31447099 PMID:31471357 PMID:31510104 PMID:31937788 PMID:32164334 PMID:32179705 PMID:32293499 PMID:32375120 PMID:32411094 PMID:32732076 PMID:32923848 PMID:33084974 PMID:33167350 PMID:33340421 PMID:33450337 PMID:33615670 PMID:33680468 PMID:33754314 PMID:33763905 PMID:33827484 PMID:34629742 PMID:34637071 PMID:34881033 PMID:34885201 PMID:35189708 PMID:35304457 PMID:35535697 PMID:36166639 PMID:36222615 PMID:36900098 PMID:36900197 PMID:37529773 PMID:37604101 More...
|
|
NCBI chr 4:151,325,969...151,368,176
Ensembl chr 4:151,326,431...151,368,176
|
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
ClinVar Annotator: match by term: Thyroid cancer, nonmedullary, 2 |
ClinVar |
PMID:12068308 PMID:12198537 PMID:12960123 PMID:16187918 PMID:24033266 |
|
NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
|
|
G |
Cbx7 |
chromobox 7 |
|
ISO |
protein:decreased expression:thyroid gland: |
RGD |
PMID:18701502 |
RGD:9587357 |
NCBI chr 7:111,460,656...111,479,231
Ensembl chr 7:111,460,656...111,477,973
|
|
G |
Cga |
glycoprotein hormones, alpha polypeptide |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10566621 |
|
NCBI chr 5:49,486,915...49,499,192
Ensembl chr 5:49,487,068...49,499,191
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
|
ISO |
ClinVar Annotator: match by term: THYROID CANCER, NONMEDULLARY, 2 | ClinVar Annotator: match by term: Thyroid cancer, nonmedullary, 2 CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD |
PMID:11150980 PMID:12727991 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19371735 PMID:19669404 PMID:19855393 PMID:20301680 PMID:20660566 PMID:20979192 PMID:21403836 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22190897 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22683711 PMID:23093928 PMID:23429430 PMID:23487764 PMID:23751039 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24803665 PMID:25326635 PMID:25346259 PMID:25695684 PMID:25741868 PMID:25742471 PMID:25914166 PMID:26467025 PMID:27195699 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28371260 PMID:28492532 PMID:29493581 PMID:31222966 PMID:31775759 PMID:33372952 PMID:34008892 PMID:168335863 More...
|
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Lrrc56 |
leucine rich repeat containing 56 |
|
ISO |
ClinVar Annotator: match by term: THYROID CANCER, NONMEDULLARY, 2 | ClinVar Annotator: match by term: Thyroid cancer, nonmedullary, 2 |
ClinVar |
PMID:11150980 PMID:12727991 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19371735 PMID:19669404 PMID:19855393 PMID:20301680 PMID:20660566 PMID:20979192 PMID:21403836 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22190897 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22683711 PMID:23093928 PMID:23429430 PMID:23487764 PMID:23751039 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24803665 PMID:25326635 PMID:25346259 PMID:25695684 PMID:25741868 PMID:25742471 PMID:25914166 PMID:26467025 PMID:27195699 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28371260 PMID:28492532 PMID:29493581 PMID:31222966 PMID:31775759 PMID:33372952 PMID:34008892 PMID:168335863 More...
|
|
NCBI chr 1:196,299,843...196,315,170
Ensembl chr 1:196,299,846...196,315,172
|
|
G |
Minpp1 |
multiple inositol-polyphosphate phosphatase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: MINPP1-related condition | ClinVar Annotator: match by term: Thyroid cancer, nonmedullary, 2 |
OMIM CTD ClinVar |
PMID:11297621 |
|
NCBI chr 1:230,354,483...230,379,730
Ensembl chr 1:230,354,438...230,379,730
|
|
G |
Nras |
NRAS proto-oncogene, GTPase |
|
ISO |
ClinVar Annotator: match by term: Thyroid cancer, nonmedullary, 2 CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD |
PMID:1654209 PMID:6587382 PMID:12727991 PMID:14508525 PMID:18633438 PMID:19880792 PMID:22499344 PMID:22773810 PMID:23392294 PMID:24006476 PMID:24033266 PMID:25741868 More...
|
|
NCBI chr 2:190,582,885...190,593,509
Ensembl chr 2:190,582,918...190,591,626
|
|
G |
Pax8 |
paired box 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15785241 |
|
NCBI chr 3:7,185,721...7,242,363
Ensembl chr 3:7,185,723...7,242,363
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15785241 |
|
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
ClinVar Annotator: match by term: THYROID CANCER, NONMEDULLARY, 2 | ClinVar Annotator: match by term: Thyroid cancer, nonmedullary, 2 |
ClinVar |
PMID:24033266 PMID:24055113 PMID:25741868 PMID:25980754 PMID:28492532 PMID:29706350 PMID:29785012 PMID:30311380 PMID:32350270 PMID:32832836 PMID:32885271 PMID:34793697 PMID:38645101 More...
|
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Srgap1 |
SLIT-ROBO Rho GTPase activating protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: SRGAP1-related condition | ClinVar Annotator: match by term: Thyroid cancer, nonmedullary, 2 |
OMIM CTD ClinVar |
PMID:23539728 PMID:25741868 PMID:28492532 |
|
NCBI chr 7:57,329,532...57,594,681
Ensembl chr 7:57,329,532...57,596,196
|
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
|
ISO |
ClinVar Annotator: match by term: THYROID CARCINOMA, FOLLICULAR |
ClinVar |
PMID:11150980 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19371735 PMID:19669404 PMID:20301680 PMID:20660566 PMID:20979192 PMID:21403836 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22190897 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22683711 PMID:23093928 PMID:23429430 PMID:23487764 PMID:23751039 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24803665 PMID:25326635 PMID:25346259 PMID:25695684 PMID:25741868 PMID:25742471 PMID:25914166 PMID:26467025 PMID:27195699 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28371260 PMID:28492532 PMID:29493581 PMID:31222966 PMID:31775759 PMID:33372952 PMID:34008892 PMID:168335863 More...
|
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27440272 |
|
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Lrrc56 |
leucine rich repeat containing 56 |
|
ISO |
ClinVar Annotator: match by term: THYROID CARCINOMA, FOLLICULAR |
ClinVar |
PMID:11150980 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19371735 PMID:19669404 PMID:20301680 PMID:20660566 PMID:20979192 PMID:21403836 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22190897 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22683711 PMID:23093928 PMID:23429430 PMID:23487764 PMID:23751039 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24803665 PMID:25326635 PMID:25346259 PMID:25695684 PMID:25741868 PMID:25742471 PMID:25914166 PMID:26467025 PMID:27195699 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28371260 PMID:28492532 PMID:29493581 PMID:31222966 PMID:31775759 PMID:33372952 PMID:34008892 PMID:168335863 More...
|
|
NCBI chr 1:196,299,843...196,315,170
Ensembl chr 1:196,299,846...196,315,172
|
|
G |
Nras |
NRAS proto-oncogene, GTPase |
|
ISO |
ClinVar Annotator: match by term: THYROID CARCINOMA, FOLLICULAR |
ClinVar |
PMID:1654209 PMID:6587382 PMID:12727991 PMID:14508525 PMID:18633438 PMID:19880792 PMID:22499344 PMID:22773810 PMID:23392294 PMID:24006476 PMID:24033266 PMID:25741868 More...
|
|
NCBI chr 2:190,582,885...190,593,509
Ensembl chr 2:190,582,918...190,591,626
|
|
G |
Prkar1a |
protein kinase cAMP-dependent type I regulatory subunit alpha |
|
ISS |
OMIM:188470 |
MouseDO |
|
|
NCBI chr10:94,621,042...94,639,534
Ensembl chr10:94,620,039...94,639,041
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISS ISO |
OMIM:188470 ClinVar Annotator: match by term: THYROID CARCINOMA, FOLLICULAR |
MouseDO ClinVar |
PMID:24033266 PMID:24055113 PMID:25741868 PMID:25980754 PMID:28492532 PMID:29706350 PMID:29785012 PMID:30311380 PMID:32350270 PMID:32832836 PMID:32885271 PMID:34793697 PMID:38645101 More...
|
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Srgap1 |
SLIT-ROBO Rho GTPase activating protein 1 |
|
ISO |
ClinVar Annotator: match by term: THYROID CARCINOMA, FOLLICULAR |
ClinVar |
PMID:23539728 |
|
NCBI chr 7:57,329,532...57,594,681
Ensembl chr 7:57,329,532...57,596,196
|
|
G |
Thrb |
thyroid hormone receptor beta |
|
ISO ISS |
CTD Direct Evidence: marker/mechanism OMIM:188470 |
CTD MouseDO |
PMID:27440272 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
|
G |
Wrap53 |
WD repeat containing, antisense to TP53 |
disease_progression |
ISO |
|
RGD |
PMID:28849066 |
RGD:21081521 |
NCBI chr10:54,282,092...54,299,908
Ensembl chr10:54,282,105...54,298,929
|
|
|
G |
Ccng1 |
cyclin G1 |
|
ISO |
mRNA:decreased expression:head and neck (human) |
RGD |
PMID:27982046 |
RGD:151361200 |
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
|
|
G |
Ccng2 |
cyclin G2 |
|
ISO |
mRNA:decreased expression:head and neck (human) |
RGD |
PMID:27982046 |
RGD:151361200 |
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
ISO |
DNA:hypermethylation |
RGD |
PMID:20846153 PMID:16721740 |
RGD:14700957, RGD:14700978 |
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Dcdc1-ps1 |
doublecortin domain containing 1, pseudogene 1 |
|
ISO |
ClinVar Annotator: match by term: Head and neck cancer |
ClinVar |
PMID:25741868 PMID:28492532 PMID:32266149 |
|
NCBI chr 3:92,486,054...92,896,696
Ensembl chr 3:92,718,047...92,896,542
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
|
ISO |
DNA:hypermethylation |
RGD |
PMID:20846153 PMID:21133595 PMID:16721740 |
RGD:14700957, RGD:14700998, RGD:14700978 |
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
|
ISO |
|
RGD |
PMID:21133595 |
RGD:14700998 |
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Kdm4c |
lysine demethylase 4C |
susceptibility |
ISO |
DNA:snps:cds, intron:p.N396D (rs2296067), IVS10G>T (rs818912) (human) |
RGD |
PMID:19339270 |
RGD:9587748 |
NCBI chr 5:88,100,710...88,306,821
Ensembl chr 5:88,100,733...88,306,818
|
|
G |
Scimp |
SLP adaptor and CSK interacting membrane protein |
|
ISO |
ClinVar Annotator: match by term: Head and neck cancer |
ClinVar |
PMID:32266149 |
|
NCBI chr10:55,507,646...55,527,764
Ensembl chr10:55,507,519...55,528,171
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25275603 |
|
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25275603 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25275603 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25275603 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Abl1 |
ABL proto-oncogene 1, non-receptor tyrosine kinase |
|
ISO |
ClinVar Annotator: match by term: Lip and oral cavity carcinoma |
ClinVar |
PMID:31775759 |
|
NCBI chr 3:14,979,853...15,083,065
Ensembl chr 3:14,979,853...15,083,065
|
|
G |
Acod1 |
aconitate decarboxylase 1 |
|
ISO |
mRNA:increased expression:cranioceervical (human) |
RGD |
PMID:37793345 |
RGD:596992333 |
NCBI chr15:79,871,819...79,881,101
Ensembl chr15:79,871,827...79,880,529
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23873848 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Ankrd17 |
ankyrin repeat domain 17 |
|
ISO |
ClinVar Annotator: match by term: Lip and oral cavity carcinoma |
ClinVar |
PMID:28580594 |
|
NCBI chr14:17,723,239...17,861,841
Ensembl chr14:17,721,932...17,862,617
|
|
G |
Atp7b |
ATPase copper transporting beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12509969 |
|
NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636
|
|
G |
B2m |
beta-2 microglobulin |
|
ISO |
ClinVar Annotator: match by term: Head and neck squamous cell carcinoma | ClinVar Annotator: match by term: Squamous cell carcinoma of the head and neck |
ClinVar |
PMID:26619011 |
|
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
exacerbates |
ISO |
mRNA:increased expression:head or neck skin (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
ameliorates |
ISO |
mRNA:increased expression:head or neck skin (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
ClinVar Annotator: match by term: Lip and oral cavity carcinoma |
ClinVar |
PMID:31775759 |
|
NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463
|
|
G |
Casp8 |
caspase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23358896 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Ccdc3 |
coiled-coil domain containing 3 |
|
ISO |
ClinVar Annotator: match by term: Lip and oral cavity carcinoma |
ClinVar |
PMID:26614431 |
|
NCBI chr17:73,031,891...73,135,173
Ensembl chr17:73,035,045...73,135,337
|
|
G |
Ccna1 |
cyclin A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23358896 PMID:29464035 |
|
NCBI chr 2:139,231,738...139,278,066
Ensembl chr 2:139,201,074...139,243,157
|
|
G |
Ccna2 |
cyclin A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29464035 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29464035 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:26909611 PMID:29464035 PMID:9796972 |
RGD:13434911 |
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccne1 |
cyclin E1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29464035 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Ccne2 |
cyclin E2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29464035 |
|
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
|
|
G |
Cdc73 |
cell division cycle 73 |
exacerbates |
ISO |
protein:increased expression:squamous epithelium (human) |
RGD |
PMID:26124004 |
RGD:11065919 |
NCBI chr13:55,357,226...55,449,690
Ensembl chr13:55,357,226...55,449,656
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29464035 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29464035 |
|
NCBI chr 7:62,886,124...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29464035 |
|
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
disease_progression |
ISO |
DNA:SNPs: :rs3731217, rs3088440 (human) ClinVar Annotator: match by term: Lip and oral cavity carcinoma CTD Direct Evidence: marker/mechanism |
ClinVar CTD RGD |
PMID:7718873 PMID:8153634 PMID:8668202 PMID:9166859 PMID:11687599 PMID:15146471 PMID:16374456 PMID:16818274 PMID:16905682 PMID:18205010 PMID:18519632 PMID:21801156 PMID:24991542 PMID:25741868 PMID:26192916 PMID:26681309 PMID:26909611 PMID:27756164 PMID:27960642 PMID:28492532 PMID:28765326 PMID:29915805 PMID:31382929 PMID:31775759 PMID:21381012 More...
|
RGD:8552291 |
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
|
|
G |
Chd4 |
chromodomain helicase DNA binding protein 4 |
|
ISO |
mRNA:increased expression:head or neck skin (human) |
RGD |
PMID:28486105 |
RGD:153323299 |
NCBI chr 4:157,898,503...157,931,632
Ensembl chr 4:157,899,391...157,931,541
|
|
G |
Cldn1 |
claudin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33665778 |
|
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
|
|
G |
Cntn4 |
contactin 4 |
|
ISO |
ClinVar Annotator: match by term: Lip and oral cavity carcinoma |
ClinVar |
PMID:28595731 |
|
NCBI chr 4:138,624,584...139,622,499
Ensembl chr 4:139,099,152...139,621,090
|
|
G |
Crebbp |
CREB binding protein |
|
ISO |
ClinVar Annotator: match by term: Head and neck squamous cell carcinoma | ClinVar Annotator: match by term: Squamous cell carcinoma of the head and neck |
ClinVar |
PMID:21390126 PMID:21680795 PMID:21796119 PMID:22832583 PMID:23334668 PMID:23685749 PMID:23778141 PMID:25741868 PMID:26087898 PMID:26619011 PMID:27257180 PMID:28492532 PMID:28970362 PMID:29551561 PMID:33560380 More...
|
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Ctnnb1 |
catenin beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34019859 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cyp2c11 |
cytochrome P450, subfamily 2, polypeptide 11 |
treatment |
ISO |
DNA:polymorphisms: :CYP2C9*2(human) |
RGD |
PMID:19954746 |
RGD:401901267 |
NCBI chr 1:246,175,216...246,211,445
Ensembl chr 1:236,762,842...236,799,066
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
treatment |
ISO |
DNA:polymorphisms: :CYP2C19*2(human) |
RGD |
PMID:19954746 |
RGD:401901267 |
NCBI chr 1:247,879,058...247,916,804
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
treatment |
ISO |
DNA:polymorphisms: :CYP2D6*4,CYP2D6*10(human) |
RGD |
PMID:19954746 |
RGD:401901267 |
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
severity |
ISO |
|
RGD |
PMID:24556606 |
RGD:150429746 |
NCBI chr13:82,193,623...82,318,229
Ensembl chr13:82,195,463...82,317,363
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
susceptibility |
ISO |
DNA:SNP,haplotype:promoter:-149C>T,-579G>T(human) |
RGD |
PMID:18455294 |
RGD:9589078 |
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
ClinVar Annotator: match by term: Head and neck squamous cell carcinoma | ClinVar Annotator: match by term: Lip and oral cavity carcinoma | ClinVar Annotator: match by term: Squamous cell carcinoma of the head and neck |
ClinVar |
PMID:15118073 PMID:15118125 PMID:15788655 PMID:17177598 PMID:17285735 PMID:19060236 PMID:19096301 PMID:20415598 PMID:21531084 PMID:22980975 PMID:23242437 PMID:23358982 PMID:23371856 PMID:24712396 PMID:24788590 PMID:25130612 PMID:25157968 PMID:25382819 PMID:25741868 PMID:25969368 PMID:26101090 PMID:26619011 PMID:28492532 PMID:28874603 PMID:29576263 PMID:29945477 PMID:31775759 PMID:33644199 PMID:33898318 PMID:34555730 PMID:36698436 More...
|
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
disease_progression |
ISO |
|
RGD |
PMID:20604875 |
RGD:126790467 |
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Erbb4 |
erb-b2 receptor tyrosine kinase 4 |
severity |
ISO |
|
RGD |
PMID:20604875 |
RGD:126790467 |
NCBI chr 9:69,523,733...70,596,743
Ensembl chr 9:69,531,481...70,596,595
|
|
G |
Fancb |
FA complementation group B |
|
ISO |
DNA:hypermethylation:promoter |
RGD |
PMID:20332657 |
RGD:11344903 |
NCBI chr X:29,403,771...29,420,484
Ensembl chr X:29,403,771...29,420,192
|
|
G |
Fancd2 |
FA complementation group D2 |
|
ISO |
|
RGD |
PMID:20935219 |
RGD:11344907 |
NCBI chr 4:146,679,014...146,743,422
Ensembl chr 4:146,679,179...146,743,412
|
|
G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
ISO |
ClinVar Annotator: match by term: Head and neck squamous cell carcinoma ClinVar Annotator: match by term: Head and neck squamous cell carcinoma | ClinVar Annotator: match by term: Squamous cell carcinoma of the head and neck |
ClinVar |
PMID:1908846 PMID:7773297 PMID:8589699 PMID:8640234 PMID:8858131 PMID:9438390 PMID:9677066 PMID:10073901 PMID:10471491 PMID:10696568 PMID:11038465 PMID:11241532 PMID:11529856 PMID:11879084 PMID:12833394 PMID:15772091 PMID:16841094 PMID:17384684 PMID:18642369 PMID:19381019 PMID:19749790 PMID:20301540 PMID:20420824 PMID:22045636 PMID:25157968 PMID:25606676 PMID:25614871 PMID:25741868 PMID:25741914 PMID:26619011 PMID:28492532 PMID:29593476 PMID:31299979 PMID:36135330 PMID:36474027 More...
|
|
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
|
|
G |
Fgfr4 |
fibroblast growth factor receptor 4 |
severity |
ISO |
DNA:SNP:exon 9: p.G388R (human) |
RGD |
PMID:17084840 |
RGD:150520023 |
NCBI chr17:9,461,541...9,476,268
Ensembl chr17:9,461,547...9,476,242
|
|
G |
Fhit |
fragile histidine triad diadenosine triphosphatase |
|
ISO |
ClinVar Annotator: match by term: Lip and oral cavity carcinoma |
ClinVar |
PMID:28580594 |
|
NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
|
|
G |
Grik2 |
glutamate ionotropic receptor kainate type subunit 2 |
|
ISO |
ClinVar Annotator: match by term: Lip and oral cavity carcinoma |
ClinVar |
PMID:26614431 |
|
NCBI chr20:52,135,325...52,833,061
Ensembl chr20:52,133,851...52,838,375
|
|
G |
Hoxa5 |
homeo box A5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22227861 |
|
NCBI chr 4:81,302,341...81,306,234
Ensembl chr 4:81,302,353...81,306,234
|
|
G |
Hoxd10 |
homeo box D10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22227861 |
|
NCBI chr 3:59,594,516...59,597,725
Ensembl chr 3:59,594,516...59,597,725
|
|
G |
Hoxd11 |
homeobox D11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22227861 |
|
NCBI chr 3:59,584,840...59,587,257
Ensembl chr 3:59,585,039...59,586,783
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
|
ISO |
ClinVar Annotator: match by term: Head and neck squamous cell carcinoma | ClinVar Annotator: match by term: Lip and oral cavity carcinoma | ClinVar Annotator: match by term: Squamous cell carcinoma of the head and neck |
ClinVar |
PMID:1904555 PMID:2105486 PMID:3510078 PMID:11150980 PMID:12727991 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 PMID:16372351 PMID:16443854 PMID:16835863 PMID:16881968 PMID:16969868 PMID:17054105 PMID:17211612 PMID:17384584 PMID:17412879 PMID:17601930 PMID:17979197 PMID:18039947 PMID:18042262 PMID:18247425 PMID:18642361 PMID:18978862 PMID:19206176 PMID:19213030 PMID:19255327 PMID:19371735 PMID:19382114 PMID:19669404 PMID:19773371 PMID:19855393 PMID:20301680 PMID:20658932 PMID:20660566 PMID:20859122 PMID:20937837 PMID:20979192 PMID:21344638 PMID:21438134 PMID:21495179 PMID:21686750 PMID:21834037 PMID:21850009 PMID:22087699 PMID:22256804 PMID:22317973 PMID:22420426 PMID:22495892 PMID:22499344 PMID:22683711 PMID:22726224 PMID:22926243 PMID:23093928 PMID:23096712 PMID:23406027 PMID:23429430 PMID:23751039 PMID:23884457 PMID:24006476 PMID:24033266 PMID:24129065 PMID:24169525 PMID:24224811 PMID:24390138 PMID:24803665 PMID:25157968 PMID:25326635 PMID:25695684 PMID:25741868 PMID:25815234 PMID:25914166 PMID:26467025 PMID:26619011 PMID:26778095 PMID:26916728 PMID:27102959 PMID:27195699 PMID:27283355 PMID:27444071 PMID:27589201 PMID:28027064 PMID:28139825 PMID:28492532 PMID:29493581 PMID:30055033 PMID:30138938 PMID:30191474 PMID:31222966 PMID:31394527 PMID:31560489 PMID:31564432 PMID:31775759 PMID:32371413 PMID:32732226 PMID:33027564 PMID:33372952 PMID:34008892 PMID:34958143 PMID:168335863 More...
|
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
| |